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ABSTRACT OF DISSERTATION 
 
 
 
 
MOLECULAR MECHANISMS OF OLFACTORY NEURODEGENERATION 
 
 
 
 Olfactory sensory decline has been associated with normal aging as well as 
neurodegenerative disorders, yet the underlying mechanisms are unclear. The overall aim 
of this dissertation was to investigate the fundamental molecular and cellular mechanisms 
associated with olfactory neurodegeneration. This investigation uses an integrative 
approach, combining proteomics and gene expression analyses with cellular and tissue-
level characterization.  Using these approaches, two model systems were investigated: 1) 
normally aging C57BL/6 mice of ages 1.5-, 6- and 20-months; and 2) a mouse model of 
elevated endogenous oxidative stress-associated neurodegeneration, namely, the 
Harlequin mutant mouse.  The first specific aim was to test the hypothesis that oxidative 
stress is associated with aging of the olfactory system. Using proteomics, I demonstrated 
that olfactory aging was accompanied primarily by increased oxidative stress-, 
mitochondrial metabolism- and synaptic/transport-associated changes.  The second 
specific aim was to test the hypothesis that the olfactory system accumulates oxidative 
stress-mediated macromolecular damage over time, predisposing it to neurodegeneration.  
Two types of protein oxidation, namely, carbonylation and nitration, accumulated with 
aging in the olfactory system. Protein and cellular targets of oxidative stress-associated 
damage were identified using redox proteomics coupled with immunohistochemical 
localization.  The third specific aim was to test the hypothesis that elevated oxidative 
stress in the olfactory system results in apoptosis/neurodegeneration. The Harlequin 
mutant mouse was critically selected and validated as a model for studies of oxidative
 stress-associated olfactory neurodegeneration at both the cellular and molecular levels.  
The Harlequin mouse had decreased levels and altered distribution of apoptosis inducing 
factor protein in mature olfactory sensory neurons, increased oxidative DNA damage and 
apoptosis in the olfactory epithelium, and pronounced cytoskeletal disorganization.  The 
molecular studies confirmed and extended our cellular data and identified several 
significantly regulated genes associated with elevated oxidative stress and apoptosis.  
This novel study, by combining contemporary proteomics and genomics with cellular and 
tissue-level analyses, has provided a road map for understanding fundamental molecular 
mechanisms of olfactory degeneration. 
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1 
CHAPTER ONE 
 
INTRODUCTION 
 
 
Olfactory impairment in aging and neurodegenerative diseases 
  
 “The quality, not the longevity, of one's life is what is important”  
         - Martin Luther King. 
 
 Neurodegeneration is one of the three themes of research interest in the NIH Blueprint for 
Neuroscience Research.  Olfactory impairment and anosmia (loss of sense of smell) have been 
associated with aging in humans  (Doty 1991b; Kovacs 2004; Murphy et al. 2002) as well as 
with several aging-associated neurodegenerative disorders including Alzheimer’s (AD), 
Parkinson’s and Huntington’s disease (Mesholam et al. 1998b).  Over the years, a number of 
neuroanatomical and immunohistochemical changes have been reported in the olfactory 
epithelium (OE) and olfactory bulbs (OBs) in aging and aging-associated neurodegenerative 
disorders, yet the precise molecular mechanisms underlying olfactory decline remain unclear.   
 Neurodegeneration has been associated with certain molecular and cellular processes that 
include elevated oxidative stress/stress response; macromolecular damage including increased 
DNA damage, protein oxidation, and lipid peroxidation; mitochondrial metabolic decline; 
increased apoptosis; and increased inflammation.  Brain research over the past decade has 
revealed that while neuronal loss by apoptosis seems to play a major role in neurodegenerative 
disorders, it is unlikely to be a predominant factor in normally aging brain (Morrison and Hof 
1997; Pollack and Leeuwenburgh 2001).  Rather, subtle molecular changes, such as oxidative 
stress-induced damage and mitochondrial impairments, appear to have a significant impact on 
neuronal functional decline in aging brain (Poon et al. 2004a).  It is possible that such functional 
impairments serve to predispose the aging brain to further insults, leading to the dysfunction and 
apoptosis that is characteristic of neurodegenerative disorders. 
 
 
2 
Interplay of environment and bioenergetics: oxidative stress 
  
 Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are potentially toxic 
by-products of normal cellular oxidative metabolism, with mitochondria as both their primary 
source as well as key target (Andersen 2004; Emerit et al. 2004).  Examples of ROS are 
superoxide (O2.), hydrogen peroxide (H2O2) and hydroxyl radical (HO.).  RNS include nitric 
oxide (NO) and its derivatives, such as peroxynitrite (-OONO; (Poon et al. 2004a).  Throughout 
life, these ROS and RNS are produced in metabolically active cells and are continuously 
scavenged by endogenous antioxidants. This is critical because ROS and RNS can react with 
proteins, lipids and nucleic acids, and consequently, result in damage of these macromolecules 
(Poon et al. 2004a).  Oxidatively damaged macromolecules may either be repaired or removed 
from the cell by various cellular processes, including DNA repair mechanisms and the ubiquitin-
proteasome system.  Under conditions of excessive ROS and/or RNS production or inadequate 
antioxidant response, the cell is considered to be under “oxidative stress.”  Oxidative stress can 
result in the post-translational modification and damage of cellular proteins, lipids, and DNA.  
Oxidative stress-associated macromolecular damage can be detrimental to the cell as a result of 
undesirable and potentially catastrophic consequences, including mutations in DNA and RNA 
which could predispose the cell to transformation and/or result in translation of 
aberrant/misfolded proteins; disruption of active sites of enzymes and misfolding of structural 
proteins; dysfunction of the ubiquitin-proteasome mechanism of protein disposal resulting in an 
accumulation of oxidatively damaged proteins as aggregates; and disruption of cellular 
membranes due to lipid peroxidation (e.g. reviewed by (Andersen 2004; Dalle-Donne et al. 2006; 
Keller et al. 2004; Poon et al. 2004a).  Cells have in-built mechanisms to sense redox imbalances 
and either arrest their cell cycle and undergo senescence or trigger self-destruction by 
programmed cell death (Dawson and Dawson 2004).    
 Oxidative stress is a major mediator of the progressive decline in cellular function during 
aging in various tissues (Andersen 2004).  In the aging brain, free radical-mediated oxidative 
stress results in the oxidation of proteins, nucleic acids, and lipids, altering the structure and 
function of these macromolecules (Beckman and Ames 1998; Levine and Stadtman 2001).  For 
example, protein carbonylation (see Figure 1.1), a type of protein oxidation, increases with aging 
in a wide range of species and tissues, including human brain (Levine and Stadtman 2001).  
3 
 Increased protein oxidation has been associated with altered protein function and reduced 
enzyme activity, leading to cellular dysfunction in aging brain as well as in age-related 
neurodegenerative diseases (Andersen 2004; Butterfield and Stadtman 1997; Dalle-Donne et al. 
2006).  Interestingly, specific proteins appear to be targeted for oxidative modification during 
aging and in several age-related neurodegenerative disorders, leaving other proteins unaltered 
(Butterfield et al. 2003).  In a collaborative pilot study of aging mice conducted by Dr. D. Allen 
Butterfield’s and our laboratories, we recently demonstrated that total protein oxidation was 
elevated in brains of old mice (Figure 1.2; (Poon et al. 2006b).  In this study we also 
demonstrated that specific proteins were oxidized, which we identified using proteomics, and 
that these oxidized proteins were functionally less active in brains of old mice (Poon et al. 
2006b).  Whether one would observe similar changes in the OE and OB remained to be 
investigated.  The capacity for replacement of olfactory sensory neurons (OSNs) in the OE and 
granule cells and periglomerular interneurons in the OB via neurogenesis may dampen the 
effects of oxidative stress by removing and replacing neurons with extensive macromolecular 
damage.  Yet, unlike the brain, the OE is constantly exposed to environmental insults which 
would significantly contribute to the oxidative stress in the olfactory system.  Cumulative 
oxidative damage, both due to exogenous and endogenous insults, may alter the cellular 
dynamics of this system and consequently lead to a functional decline of damaged cellular 
targets, an increase in cell death and decrease in neurogenesis.  Literature clearly substantiates 
the involvement of oxidative stress in the olfactory system in aging and neurodegenerative 
diseases and the uniqueness of this system suggests that the mechanisms of oxidative stress 
associated cellular damage, death and antioxidant response may be different from those observed 
in the brain.   
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Figure 1.1.  (Modified from (Levine and Stadtman 2001).  The graph shows the protein carbonyl 
content from various tissues and species as a function of fraction of lifespan. The green dashed 
line shows the trend towards increased protein carbonylation in aging human brain (clear 
squares), which appears to be cumulative, unlike the biphasic change observed in other tissues.  
 
 
human dermal fibroblasts
human lens 
rat liver 
house fly brain
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Figure 1.2.  (From(Poon et al. 2006b).  The graph shows the total protein carbonyl level in 
brains of young and old C57BL/6 mice determined by slot blot analysis.  The total carbonyl level 
was significantly higher (~ 40%) in the brains of old mice when compared to young. Bars, 
±S.E.M. *p < 0.05, n = five samples from young and five samples from old cohorts. 
 
 
 
 
6 
Oxidative stress in olfactory aging and neurodegeneration 
 
 Oxidative stress is associated with aging and many age-related diseases.  Reports from 
our laboratory and others have shown the occurrence of oxidative stress in the olfactory system 
in aging and neurodegenerative diseases such as AD (Chuah and Getchell 1999; Getchell et al. 
2002a; Getchell et al. 2003a; Getchell 2002; Getchell et al. 2003b; Getchell 2001a; Getchell et al. 
2003c; Getchell et al. 1995; Perry et al. 2003; Perry et al. 2000; Rama Krishna et al. 1995).  The 
reduction in levels of xenobiotic metabolizing enzymes (Krishna et al. 1995) and in the 
expression of heat-shock protein 70 in human olfactory receptor neurons (Getchell et al. 1995) 
with aging indicated that secretory and neuronal impairments in stress responses may contribute 
to age-associated loss of olfactory function.  Elevated cellular deposits of lipofuscin, the oxidized 
protein-containing aging pigment (Terman and Brunk, 2006), was observed in the OE of aging 
rats (Naguro et al. 1992), indicating oxidative stress.  In AD patients, the protein oxidation index 
3-nitrotyrosine (3-NT) was elevated in OSNs, further suggesting a direct involvement of 
oxidative stress in olfactory impairment (Getchell et al. 2003b).  In the OBs of elderly humans, 
oxidative stress was evidenced by high levels of lipofuscin as well as the presence of numerous 
microglia (Getchell 2001b; Getchell and Getchell 2002).   
 At the molecular level, alterations in gene expression have been reported by our group in 
the OE of the senescence-accelerated mouse (SAM) model, including an up-regulation of genes 
associated with oxidative stress, extracellular matrix and immunosenescence (Getchell et al. 
1995; Getchell et al. 2003d).   
 Several intriguing unanswered questions remained, such as, whether the aging olfactory 
system accumulated oxidative macromolecular damage, and if so, which specific proteins are 
targets of oxidation in the olfactory system?  Do targets of protein oxidation in the olfactory 
system differ from those identified in our whole brain pilot proteomics study?  Which cell types 
are vulnerable to the effects of oxidative stress?  Could we then simulate the physiological, 
cellular and molecular changes observed in the aging olfactory system in an adult mouse model 
with elevated endogenous oxidative stress?   
 
 
 
7 
The need for a model of oxidative stress-associated olfactory degeneration 
 
 The evidence described clearly establishes oxidative stress as a major player in olfactory 
impairment observed in aging and age-associated diseases.  Various studies have investigated the 
direct effects of exogenous oxidants on olfactory pathology and function (Genter et al. 2002) and 
have contributed significantly to our understanding of the effects of these oxidants on olfactory 
neurons.  In contrast, few studies have addressed the role of endogenous oxidants, namely ROS 
and RNS, derived from normal cellular metabolism, on the olfactory system.   
  Upon careful consideration of several available mouse models, I selected the Harlequin 
mutant mouse for pilot studies of the role of endogenous oxidative stress in the olfactory system.  
The Harlequin mutant mouse is a model of adult-onset neurodegeneration and carries an X-
linked recessive mutation in the Pdcd8 (programmed cell death 8) gene. The  protein product of 
Pdcd8 is known as apoptosis-inducing factor (AIF; (Klein et al. 2002; Susin et al. 1999).  This 
protein has dual physiological functions: first, the maintenance of normal mitochondrial 
metabolism and consequently low levels of oxidative stress in neurons via its oxidoreductase 
domain, and second, the induction of programmed cell death in a caspase-independent manner 
via its apoptotic domain (Cheung et al. 2006; Modjtahedi et al. 2006).  The Harlequin mouse 
exhibits an 80% reduction in Pdcd8 mRNA and AIF protein expression, increased oxidative 
stress, and mitochondrial bioenergetic impairment in several tissues including the brain and 
retina (Klein et al. 2002).  Mitochondrial bioenergetic decline, leading to increased ROS and 
RNS production, is a hallmark of brain aging and age-associated neurodegenerative diseases 
(Rego and Oliveira 2003; Sastre et al. 2003).  DNA oxidation is elevated in the cerebellum and 
retina of Harlequin mice, leading to increased mutations and apoptotic cell death of certain 
neurons (Klein et al. 2002; Stringer et al. 2004; Vahsen et al. 2004).  A schematic (from (Klein 
and Ackerman 2003) of the proposed mechanism by which the Harlequin mutation leads to 
elevated oxidative stress and apoptosis in neurons is shown in Figure 1.3.  The characteristics 
described above made the Harlequin mouse an attractive candidate for systematic studies of 
oxidative stress and neurodegeneration in the olfactory system. 
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Figure 1.3.  (From (Klein and Ackerman 2003).  Elevated oxidative stress leads to apoptosis in 
the Harlequin mouse.  The diagram shows a model showing the proposed events occurring in 
neurons of Harlequin mutant mice, in which AIF levels are substantially reduced, leading to cell 
death. 
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Looking at the big picture: an integrative approach 
 
 “….though each was partly in the right, and all were in the wrong!” from The Blind Men 
and the Elephant, by John Godfrey Saxe. 
  
 Our knowledge of any system is limited by the pieces of the puzzle available to us, 
namely scientific data, and by our own interpretation.  Scientific data is further limited by the 
tools available to us for investigation and how we use them.  In recent years, the availability of 
many new methodologies along with computerization have expedited the process of gathering 
data.  Various approaches, including genomics, proteomics and phenomics, have made it 
possible to simultaneously investigate changes occurring in numerous molecules and cellular 
pathways.  Yet, surprisingly few studies have been reported in aging that integrate genomics, 
proteomics and cellular analyses (Raghothama et al. 2005; Weinreb et al. 2007).  In the olfactory 
system, gene expression profiling has been used advantageously to unravel cell-type specific 
gene expression in the mouse (Yu et al. 2005), apoptosis and tissue remodeling (Getchell et al. 
2006; Shetty et al. 2005), neuro-immunological interactions (Getchell et al. 2006; Kwong et al. 
2004), senescence-associated gene regulation (Getchell et al. 2004; Getchell et al. 2003d), and 
tissue differences in gene expression in AD brains (Li et al. 2004).  In contrast, to our 
knowledge, no proteomics studies have been reported in the olfactory system prior to the results 
reported in this dissertation.  While transcriptional analyses alone have provided a wealth of 
information, in order to truly understand the role of oxidative stress-associated degenerative 
changes in the olfactory system, a physiologically relevant integrative approach would be 
essential.  In this study I have used a combination of proteomics, redox proteomics and gene 
expression analyses, complemented with cellular localization and tissue characterization.  Using 
these approaches, I investigated two model systems: 1) normally aging C57BL/6 mice of ages 
1.5-, 6- and 20-months; and 2) a mouse model of elevated endogenous oxidative stress-
associated neurodegeneration, namely, the Harlequin mutant mouse.   
 This dissertation, which combines contemporary proteomics and genomics with cellular 
and tissue-level analyses to obtain a comprehensive “systems level” understanding of olfactory 
degeneration, is unique in the olfactory neurobiology field.  I hope that this novel approach will 
serve as a kindling for future integrative studies of olfactory neurodegeneration. 
10 
Specific aims 
 
 The overall aim of my dissertation was to investigate molecular and cellular mechanisms 
associated with olfactory neurodegeneration. 
 
 Specific aim 1 was to test the hypothesis that oxidative stress is associated with aging of 
the olfactory system.  The results of my first specific aim were published in the paper: 
“Proteomic identification of differentially expressed proteins in the aging murine olfactory 
system and transcriptional analysis of the associated genes.” H.F. Poon, R.A. Vaishnav (co-
first author), D.A. Butterfield, M.L. Getchell, T.V. Getchell;  J. Neurochem. 2005; 94, 380–392.  
These results were also presented at the Association for Chemoreception Sciences meeting in 
April, 2005.  
 
 Specific aim 2 was to test the hypothesis that the olfactory system accumulates oxidative 
stress-mediated macromolecular damage over time, predisposing it to neurodegeneration.  The 
results of my second specific aim were published in the paper: “Oxidative stress in the aging 
murine olfactory bulb: redox proteomics and cellular localization.” R.A. Vaishnav, M.L. 
Getchell, H.F. Poon, K.R. Barnett, W.M. Pierce, J.B. Klein, S.A. Hunter, D.A. Butterfield, T.V. 
Getchell; J.  Neurosci. Res., 2007; 85(2):373-85.  These results were also presented at the 
Association for Chemoreception Sciences meeting in April, 2006. 
 
 Specific aim 3 was to test the hypothesis that elevated oxidative stress in the olfactory 
system results in apoptosis/neurodegeneration.  The results of my third specific aim were 
submitted for peer review on April 4, 2007 to Journal of Neuroscience Research in a manuscript 
titled: “Cellular and molecular characterization of oxidative stress in the olfactory 
epithelium of the Harlequin mutant mouse.” R.A. Vaishnav, M.L. Getchell, L. Huang, M.A. 
Hersh, A.J. Stromberg, T.V. Getchell. 
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2.6 and 2.7; and 10% to the research shown in Figures 2.4 and 2.8. 
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Introduction 
 
 Olfactory impairment and anosmia (loss of sense of smell) have been associated with 
aging in humans (Doty 1991b; Murphy et al. 2002) as well as with several age-associated 
neurodegenerative disorders including Alzheimer’s and Parkinson’s diseases (Mesholam et al. 
1998b). Many neuroanatomical and immunohistochemical changes have been documented in the 
olfactory epithelium (OE) and olfactory bulbs (OB) of aging humans. These include a reduction 
in surface area and an increase in susceptibility to neuronal apoptosis in the OE and a reduction 
of OB size and cell number (Kovacs 2004). In the human OE, reduced adrenergic innervation of 
blood vessels and glands (Chen et al. 1993) suggested impaired vasomotor and secretory 
responses.  The age-related reduction in levels of xenobiotic metabolizing enzymes (Krishna et 
al. 1995) and in HSP70 expression by human olfactory receptor neurons (Getchell et al. 1995) 
indicated that secretory and neuronal impairments in stress responses may also contribute to the 
loss of olfactory sensibility with age. In the OB of elderly humans, high levels of lipofuscin as 
well as the presence of numerous microglia, occasional β-amyloid fibrils and rare neurofibrillary 
tangles were observed (Getchell 2001b; Getchell and Getchell 2002). 
Molecular alterations in the aging murine olfactory epithelium have been reported at the 
transcriptional level in OE of senescence-accelerated mouse models (Getchell et al. 1995; 
Getchell et al. 2003d), where there was a down-regulation of PI3-kinase and ERK signaling, up-
regulated oxidative stress indicators, possible disruption of the extracellular matrix and a marked 
immunosenescence. However, the precise molecular changes occurring in the normally aging 
murine olfactory system, both at the protein and transcriptional level, have not been reported 
previously. In this study, we utilized an unbiased fundamental proteomic analysis as a discovery-
based method to identify differentially expressed proteins in the aging OE and OB. We report 
significant molecular changes in the aging murine OE and OB at the protein and transcriptional 
levels. This study provides a basis on which to formulate future hypothesis-driven experiments to 
determine the mechanisms by which the differentially expressed proteins are modulated in aging. 
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Materials and Methods 
 
Animals and tissue harvesting from old and young mice  
 A total of 16 C57BL/6 male mice were obtained from Harlan, US and were of two ages:  
the first group consisted of eight 80-week old mice (“old mice”) that were maintained as part of 
the National Institute on Aging Aged Rodent Colonies, and the second group consisted of eight 
6-week old mice (“young mice”).  Six week old mice were chosen for this study as they are 
sexually mature, young adults with a functionally fully-developed olfactory system. The mice 
were maintained in an animal facility at the Department of Laboratory Animal Research on a 12 
h light:dark cycle in Bioclean units with sterile-filtered air and provided food and water ad 
libitum.  All protocols were implemented in accordance with NIH guidelines and approved by 
the University of Kentucky Institutional Animal Care and Use Committee.  The body weights for 
the old mice ranged from 32 to 35 g and for the young mice from 19 to 24 g.  Following 
euthanasia with CO2, microdissection was performed to isolate the OE and the OB following a 
procedure previously reported (Getchell et al. 2004; Getchell et al. 2002c).  Immediately 
following tissue harvesting, the tissues were weighed and snap frozen in liquid N2.  For the old 
mice, the OE weight (mean + SD) was 24.5 + 8.3 mg and for the OB was 32.6 + 3.3 mg; for the 
young mice, the average OE weight was 13.8 + 2.3 mg and for the OB was 25.4 + 5.3 mg.  The 
OEs and OBs from five old and five young mice were used for proteomic analysis; the OEs and 
OBs from three old mice and three young mice were used for RNA extraction and subsequent 
real-time RT-PCR.   
 
Proteomics sample preparation 
 The OE and OB samples were homogenized in a lysis buffer (10 mM HEPES, 137 mM 
NaCl, 4.6 mM KCl, 1.1 mM KH2PO4, 0.6 mM MgSO4 and containing the protease inhibitors 
leupeptin (0.5 mg/mL), pepstatin (0.7µg/mL), trypsin inhibitor (0.5 µg/mL), and PMSF (40 
µg/mL)). Homogenates were centrifuged at 15,800 g for 10 min to remove debris. The 
supernatant was extracted to determine the concentration by the BCA method (Pierce, Rockford, 
IL, USA). 
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Two-dimensional gel electrophoresis  
 Samples of the proteins in the OE and OB were prepared as previously described (Poon 
et al. 2004b). Five individual 2D gels for OE of old mice and five individual 2D gels for OE of 
young mice (for a total of ten) were run. Similarly, a total of ten 2D gels were run for OB. 
Briefly, 200 μg of protein were applied to a pH 3-10 ReadyStrip™ IPG strip (Bio-Rad, Hercules, 
CA) for isoelectric focusing (IEF), based on the pI or isoelectric pH of the protein. The focused 
IEF strip was stored at –80oC until second dimension electrophoresis was performed. For second 
dimension electrophoresis, Linear Gradient (8-16%) Precast criterion Tris-HCl gels (Bio-Rad, 
Hercules, CA) were used to separate proteins according to their molecular weight (MrW). 
Precision ProteinTM Standards (Bio-Rad, Hercules, CA) were run along with the samples. After 
electrophoresis, the gels were incubated in fixing solution for 20 min. Sypro Ruby stain were 
used to stain the gels for 2 hours. The gels were placed in deionized water overnight for 
destaining. 
 
Image analysis 
 The gels were scanned and saved in TIF format using a Storm 860 Scanner (Molecular 
Dynamics). PDQuest (Bio-Rad, Hercules, CA) was used for matching and analysis of visualized 
protein spots among differential gels.  The principles of measuring intensity values by 2D 
analysis software are similar to those of densitometric measurement.  To determine the amount 
of protein per spot, the intensity of the average background of the entire gel was subtracted from 
that of each spot for normalization.  This was repeated for each gel.  After completion of spot-
matching, the normalized intensity of each protein spot from five individual gels from the two 
cohorts was compared between groups using a two-sample Student’s t-test.  Only spots with p-
values < 0.05 were selected for trypsin digestion. Similar analyses were done for both OE and 
OB. 
 
Trypsin digestion 
 Samples were digested using the techniques previously described (Poon et al. 2004b) 
Briefly, the selected protein spots were excised and washed with ammonium bicarbonate 
(NH4HCO3), then acetonitrile at room temperature. The protein spots were incubated with 
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dithiothreitol, then iodoacetamide solutions. The gel pieces were digested with 20 ng/µl modified 
trypsin (Promega, Madison, WI) in 25 mM NH4HCO3 with the minimal volume to cover the gel 
pieces. The gel pieces were chopped into smaller pieces and incubated at 37°C overnight in a 
shaking incubator. 
 
 
Mass spectrometry 
 Digests (1 μL) were mixed with 1 μL α-cyano-4-hydroxy-trans-cinnamic acid (10 
mg/mL in 0.1% TFA:ACN, 1:1, v/v).  The mixture (1 μL) was deposited onto a fast evaporation 
nitrocellulose matrix surface, washed twice with 2 μL 5% formic acid, and analyzed with a 
TofSpec 2E (Micromass, UK) MALDI-TOF mass spectrometer in reflectron mode. The mass 
axis was adjusted with trypsin autohydrolysis peaks (m/z 2239.14, 2211.10, or 842.51) as lock 
masses. The MALDI spectra used for protein identification from tryptic fragments were searched 
against the NCBI protein databases using the MASCOT search engine 
(http://www.matrixscience.com).  Peptide mass fingerprinting used the assumption that peptides 
are monoisotopic, oxidized at methionine residues and carbamidomethylated at cysteine residues 
(Castegna et al. 2002a);(Castegna et al. 2003);(Castegna et al. 2004). Up to one missed trypsin 
cleavage was allowed. Mass tolerance of 150 ppm was the window of error allowed for matching 
the peptide mass values.  
 
Protein identification 
 All the mass spectra (not shown) of the peptides were matched to the mass spectra in 
MSDB protein databases. A probability-based Mowse score was assigned for each protein 
identified to indicate the probability that the match between the database and the experimental 
protein is a random event. Scores greater than 61 were considered significant. Thus, if a match 
has a score higher than 61, the match has a probability lower than 0.05. All protein 
identifications agreed with the expected MrW and pI range based on their positions on the gel. 
 
Immunochemical analysis 
 The linearity of the anti-cyclophilin A (PPIA) and anti-ferritin heavy chain (FTH1) 
antibodies was measured by loading different amounts of protein from mouse tissue (OE for 
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PPIA and OB for FTH1) into the slots. Briefly, 2 μL of the samples (2 μg/μL) were treated with 
an equal volume of Laemmli buffer (0.125M Trizma base, 4%SDS, 20% glycerol) for 20 
minutes. Levels of PPIA and FTH1 were measured by slot-blot with 1 μg of protein from OE or 
OB per slot, respectively. The slot blots were detected on the nitrocellulose paper using a 
primary rabbit anti-cyclophilin A antibody (1:500, UpState, Lake Placid, NY) or anti-FTH1 
antibody (1:500, Alpha-Diagnostic, San Antonio, TX) and then a secondary anti-mouse IgG 
(Sigma, St. Louis, MO) antibody. The resultant stain was developed by application of Sigma-
Fast 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium (BCIP/NBT) tablets followed 
by density measurement by Scion-Image software package (Scion, MD). 
 
RNA extraction from mouse OE and OB tissue and reverse transcription (RT) 
 RNA was extracted from OE and OB tissues harvested from three old and three young 
mice. Frozen tissue was homogenized in 1 ml of Tri-reagent using a sterile, RNase-free dounce. 
The tissue was further disrupted using a Qiashredder column (Qiagen, Inc., Valencia, CA) as per 
the manufacturer’s protocol. RNA was extracted according to the TRI-reagent method 
(Molecular Research Center, Inc., Cincinnati, OH) and was further purified as per the Qiagen 
RNeasy mini kit RNA Cleanup Protocol (Qiagen, Inc., Valencia, CA). The concentration and 
quality of the RNA were assessed by spectrophotometry (Beckman Coulter, Inc., Fullerton, CA) 
and with a Bioanalyzer (Agilent Technologies, Palo Alto, CA). Reverse transcription was 
performed as per the protocol for the GeneAmp RNA PCR kit (Applied Biosystems, Inc., Foster 
City, CA).  
 
Primer design 
 For real-time PCR validation studies, we used the following primer sequences (forward 
primer; reverse primer; annealing temperature; reference): 
OE: Aco2 [tgggtggtgattggagatga; atctgggtctcgttgaaggt; 53 C; (Tabuchi et al. 2003)];  Aldh2 
[acctggataaagccaatt; tacccagtttatcaggagc; 50 C; (Rout and Armant 2002)]; Ppia 
(ccagggtggtgactttacac; cggaaatggtgatcttcttg; 53 C; MGI:3026778). 
OB: Mdh1 (tggaccacaaccgagcaaa; tccccagataatgacattctttacatc; 55 C; Primer Express); Eno1 
(tattgcgcctgctcggtta; tccatctcgatcagcttgt; 55 C; Primer Express); Dnm1 (atgccctcaagatcgctaagg; 
cgtcccgcgcatctgt; 55 C; Primer Express); Fth1 [(gatcaacctggagttgtatgcc; gatattctgccatgccagcttc; 
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55 C; (Carper et al. 2001)]; Atp5a1 (tggtggaattctcttcaggtta; ccaaacacgacaactccaacatt; 55 C; 
Primer Express); Omp [gacattcttctagctgctcc; cagctttggccagcaggg, 55 C, (Buiakova et al. 1994)]. 
All primer pairs spanned at least one intron, with the exception of Omp (an intronless gene), to 
allow for distinction of mRNA from possible genomic DNA amplification. 
 
Real-time polymerase chain reaction 
 A cDNA amount equivalent to 10 ng total RNA per well was used for real-time PCR 
analysis. Experimental samples, standards and no-template controls were all run in triplicate. 
Standard curves were plotted for standards with concentrations of cDNA equivalent to 10 ng, 5 
ng, 3.75 ng and 2.5 ng of RNA.  Each reaction mix (one well) consisted of 1× QuantiTect SYBR 
Green PCR Master Mix, cDNA, DEPC water, and 300 nM each of forward and reverse primers.  
The real-time PCR reaction was carried out on a ABI Prism 7000 (Applied Biosystems, Inc.) 
using the following parameters: 50 °C for 2 min; 95 °C for 15 min; 40 cycles of 94 °C for 15 s, 
specific primer annealing temperature (see Primer design) for 30 s, and 72 °C for 1 min.  Finally, 
a dissociation protocol was also run at the end of each run to verify the presence of a single 
product with the appropriate melting point temperature for each amplicon. To further ascertain 
the specificity and size of the PCR products, the products were run alongside molecular weight 
markers on a 2% agarose gel in 1xTAE at 100V for 50 min. The gel was stained with ethidium 
bromide (Sigma) and visualized using UV light.  
 The data were analyzed by setting a specific threshold for each gene at the approximate 
midpoint of the exponential phase of amplification using the methodology reported by Kwong et 
al., 2004.  The resultant threshold cycle (CT) values for each of the three biological replicates 
were averaged.  Control and experimental conditions were evaluated statistically using an 
unpaired t-test.  Standard curves were generated for each gene of interest and R2 values were 
calculated and verified to be >0.90 for all the genes studied.  Using the standard curves, CT -
values were converted to relative amounts of cDNA; the change in CT value inversely correlates 
with the direction of change of gene expression.  
An unpaired t-test was carried out to determine the statistical significance of differences in the 
expression of each gene between the young and old mice, and fold changes were calculated.
18 
Results 
 
Proteomic analysis of the aging olfactory epithelium 
 In comparison to OE of young mice, the OE of old mice had 9 proteins that were 
differentially expressed (7 up- and 2 down-regulated; Figure 2.1, left). Seven of the 9 proteins 
matched the protein database with statistical confidence, and 6 of the 7 had protein names 
assigned to their accession numbers. Figure 2.2 shows representative gels for the OE from old 
and young mice. The proteins that were expressed differentially in the OE of old vs young mice 
are summarized in Table 2.1. Figure 2.3 shows the relative expression levels of these nine 
proteins in the OE of old mice as compared to that of young mice. Aldolase 1 (ALDO1), 
cyclophilin A (peptidyl prolyl isomerase A or PPIA), mitochondrial aconitase 2 (ACO2), an 
unnamed protein product (spot number 8007) and two unidentified proteins (spot numbers 405 
and 6401) were up-regulated; and mitochondrial aldehyde dehydrogenase 2 (ALDH2) and 
albumin 1 (ALB1) were both down-regulated in the OE of the old mice as compared to that of 
the young mice. The identified proteins are listed in Table 2.2.   
 
Immunochemical validation of PPIA 
 To demonstrate confidence in the proteomic identification of proteins in the OE and to 
confirm the proteomic data for PPIA, we carried out immunochemical analysis using slot-blot 
technology. We showed that our antibody-antigen reaction was linear (Figure 2.4, top) and that 
the level of PPIA  was significantly greater (1.3 fold) in the OE of old mice when compared to 
that of the young mice (Figure 2.4, bottom). This concurs with the proteomic data. 
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Figure 2.1. Flowchart illustrating experimental design and progression. 
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Figure 2.2. Two-dimensional gel electrophoresis of OE protein. Representative 2D gels of 
proteins from OE of young and old mice (left); expanded images of protein spots that are 
significantly different (p < 0.05) between the young and old mouse OE (right). 
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Figure 2.3. Proteins present in significantly different amounts in the OE of young and old mice.  
Proteins expressed at significantly (p<0.05) different levels in the OE of old mice (n=5) relative 
to young (n=5) are shown as % of young. Error bars represent standard errors. 
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   Table 2.1.  Spot densities of proteins expressed at  
   significantly different levels (p<0.05) in OE 
 
Spot 
no. Young ±SE Old ±SE p-value FC
507 100 27.76 330.29 64.64 1.13E-02 3.3
1006 100 14.57 168.40 13.99 9.57E-03 1.7
1802 100 25.89 297.02 64.78 2.23E-02 3.0
2802 100 23.24 205.87 26.10 1.63E-02 2.1
5602 100 7.87 75.81 5.40 3.49E-02 1.3
6702 100 9.00 55.75 13.10 2.38E-02 1.7
8007 100 7.06 182.24 22.67 8.52E-03 1.8
405 100 23.18 270.35 68.91 4.72E-02 2.7
6401 100 22.28 244.61 55.72 4.25E-02 2.4
 
Mean protein spot densities for the OE of old mice (n=5) 
are shown here as % of young (n=5); SE, Standard 
Error; FC, fold change; shaded cells, proteins less 
abundant in old OE relative to young. 
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Table 2.2. Differentially expressed proteins identified in the OE. 
 
 
 
 
 
 
 
 
Proteins were trypsinized and analyzed by Mass Spectrometry in order to ascertain their 
identities. Proteins with a Mowse score ≥ 61 were considered to be identified at a statistically 
significant level. Shaded cells, proteins less abundant in old vs. young OE; MrW, molecular 
weight; pI, isoelectric pH. 
 
Spot no. Identified proteins
Accession 
no.
Mowse 
Score
% 
sequence 
coverage
No. of 
peptide 
match MrW pI
507 aldolase 1 gi|42490830 62 17 6 39.4 8.5
1006 cyclophilin A gi|6679439 83 34 7 18.1 7.7
1802 mitochondrial aconitase 2 gi|18079339 68 15 10 86.2 8.1
2802 mitochondrial aconitase 2 gi|18079339 140 22 16 86.2 8.1
5602
mitochondrial aldehyde 
dehydrogenase 2 gi|6753036 94 23 10 27.0 7.5
6702 albumin 1 gi|33859506 234 48 26 70.7 5.8
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Figure 2.4. Immunochemical analysis by slot blot of cyclophilin A (PPIA) protein in OE of 
young and old mice.  (Top) Anti-PPIA antibody showed linearity (R2 > 0.95) against different 
amounts of PPIA in slot blots. (Bottom) The PPIA in OE of old mice is significantly higher (p < 
0.05) than that in OE of young mice. 
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Transcriptional analysis of selected proteins in the aging olfactory epithelium 
 Based on their relevance to aging and the proteomics findings, the genes selected for 
transcriptional analysis of the OE were Aco2, Ppia and Aldh2. Of these, Aco2 and Aldh2, for 
example, are both mitochondrial enzymes involved in metabolism and in the maintenance of 
intracellular homeostasis. Aco2 is a TCA cycle enzyme that is a specific target of mitochondrial 
oxidative stress during aging while Aldh2 is proposed to protect cells against oxidative stress. 
The third gene chosen for transcriptional analysis by real time RT-PCR was Ppia, which has 
been shown to be a protector against oxidative stress. The gene Aldo1, which is associated with 
aging and oxidative stress as well, was not chosen for transcriptional analysis as it exists in 
multiple isoforms in mouse tissues. Although ALB1 protein was also identified and found to be 
down-regulated in the old OE, the lower levels of ALB1 may reflect a reduced blood flow or 
constricted blood vessels in the OE with aging, or, alternatively, its identification could also be a 
sampling artifact of obtaining highly vascularized tissue, and hence it was not selected for 
transcriptional analysis. 
 Real-time RT-PCR was carried out using RNA extracted from OE of 3 young and 3 old 
mice for the genes Aco2, Ppia and Aldh2 as well as Omp (olfactory marker protein). The 
resultant amplification curves were plotted and the CTs were determined (Figure 2.5). Using 
standard curve analysis, relative quantities were calculated for OE genes from old and young 
mice, based on their relative mean CT values. The specificity of the PCR reaction was confirmed 
by (a) matching the amplicon melting temperature obtained by dissociation curve analysis to the 
calculated melting temperature (Figure 2.5, insets 1-3) and (b) the presence of a single band of 
correct size on an ethidium bromide-stained 2% agarose gel (Figure 2.5., inset 4). 
 Based upon the real-time RT-PCR analysis, the transcripts for Aco2 was determined to be 
present and significantly (p<0.05) up-regulated 1.4-fold in the OE of old mice as compared to 
young (Table 2.3). This up-regulation was in concordance with the increase in the protein level 
of ACO2 in the aged OE. The transcripts for Ppia and Aldh2 were expressed in the OE but 
showed no significant difference between old and young mice. Aldh2 transcripts were relatively 
considerably less abundant (higher CT ) compared to other genes in this study. Omp mRNA, 
which is expressed in mature olfactory receptor neurons (Buiakova et al. 1994) and is used as an 
internal standard for OE, was highly abundant in both old and young mice and was significantly 
down-regulated 1.3-fold in the old compared to young OE (Figure 2.5).  
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Figure 2.5. Relative expression of mRNAs in OE. 
Real time RT-PCR data for three of the proteins identified in the proteomic analysis, Aco2, 
Aldh2, Ppia as well as for Omp, show the relative amplification of mRNA from OE of 3 young 
and 3 old mice; reactions were done in triplicate. Insets in first three graphs, dissociation curve 
confirming the presence of a unique PCR product; inset in Omp graph shows 2% agarose gel of 
real-time RT-PCR products for Aco2, Aldh2 and Ppia (lanes 2-4). 
27 
 
   Table 2.3. Comparison of results of real time RT-PCR and proteomics in OE. 
 
Mean protein spot densities for the OB of old mice (n=5) are shown as % of young 
(n=5); SE, Standard Error; FC, fold change; shaded cells, proteins less abundant in 
old OB relative to young.  cDNA from OE of 3 old mice vs. 3 young mice were 
analyzed (3 technical replicates per mouse); CT, cycle threshold, is expressed as 
mean ± standard deviation; bold indicates p < 0.05 and concordance in the 
directions of fold change of the protein and mRNA; NSD, no significant difference. 
Gene name Young Old p -value FC (RNA) FC (Protein)
CT CT Old vs Young Old vs Young
Aco2 23.0±0.1 22.5±0.5 1.78E-02 1.4 2.0
Aldh2 29.9±0.7 30.1±0.9 8.18E-01 NSD 1.3
Ppia 20.0±0.3  1.87E-01 NSD 1.720.3±0.7
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Proteomic analysis of the aging olfactory bulb 
 In comparison to OB of young mice, the OB of old mice had 20 proteins that were 
differentially expressed (Figure 2.1), of which 6 matched the protein database with statistical 
confidence. Figure 2.6 shows the representative gels from OB of old and young mice. The 
proteins that were expressed differentially in the OB of old vs young mice are summarized in 
Table 2.4. In Figure 2.7, we have shown the relative expression of these 20 proteins in OB of old 
mice as compared young mice. ATP synthase isoform 1 (ATP5A1), enolase 1 (ENO1), ferritin 
heavy chain (FTH1), malate dehydrogenase 1 (MDH1), tropomyosin alpha 3 chain (TPM3) and 
10 non-identified proteins (spot numbers 109, 110, 1102, 1501, 1605, 1702, 4204, 4901, 5302, 
5506, 6106) were up-regulated; and dynamin-1 (DNM1) and four other proteins (spot numbers 
504, 2704, 4201 and 6204) that were not identified were down-regulated in OB of the old mice 
as compared to the young mice. Table 2.5 lists the proteins identified.  
 
Immunochemical validation of FTH1 
 To demonstrate confidence in the proteomic identification of proteins in the OB and to 
confirm the proteomic data for FTH1, we carried out immunochemical analysis using slot-blot 
technology. We demonstrated that the antibody showed linearity against FTH1 (Figure 2.8, top) 
and that the level of FTH1 was significantly higher (2.7 fold) in the OB of old mice than of 
young mice (Figure 2.8, bottom).  This concurs with the proteomic data.  
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Figure 2.6. Two-dimensional gel electrophoresis of OB protein. 
Representative 2D gels of proteins from OBs of young and old mice (left); expanded images of 
protein spots that are significantly different (p < 0.05) between the young and old mouse OB 
(right). 
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Figure 2.7.  Proteins present in significantly different amounts in the OB of young and old mice.  
Proteins expressed at significantly (p<0.05) different levels in the OB of old mice (n=5) relative 
to young (n=5) are shown as % of young. Error bars represent standard errors. 
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 Table 2.4. Spot densities of proteins expressed at  
significantly different levels (p<0.05) in OB. 
 
 
 
Spot no. Young ±SE Old ±SE p- Value FC
109 100 128.6 541.5 24.8 9.77E-03 5.4
110 100 87.1 572.4 21.9 7.66E-04 5.7
504 100 12.3 51.5 11.9 2.17E-02 2.0
604 100 21.0 187.9 25.8 2.95E-02 1.9
1102 100 17.6 173.9 13.3 1.00E-02 1.7
1501 100 61.7 332.2 26.2 8.51E-03 3.3
1605 100 46.1 265.4 31.5 1.81E-02 2.7
1702 100 53.3 256.8 23.4 2.74E-02 2.6
2704 100 5.9 42.3 13.7 4.75E-03 2.5
3802 100 9.3 58.1 11.2 2.08E-02 1.7
4201 100 4.5 62.7 11.4 1.61E-02 1.7
4204 100 25.9 212.7 15.5 5.75E-03 2.1
4503 100 38.1 234.7 15.8 1.14E-02 2.3
4901 100 61.6 295.8 14.1 1.47E-02 3.0
5104 100 28.5 242.3 33.2 1.16E-02 2.4
5302 100 33.8 191.1 10.0 3.24E-02 1.9
5506 100 31.6 255.9 20.5 3.26E-03 2.6
6106 100 81.2 361.7 36.2 1.86E-02 3.6
6204 100 8.0 34.1 19.8 1.50E-02 3.3
7206 100 32.8 290.7 35.2 4.14E-03 2.9
Mean protein spot densities for the OB of old mice 
(n=5) are shown as % of young (n=5); SE, 
Standard Error; FC, fold change; shaded cells, 
proteins less abundant in old OB relative to young. 
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Figure 2.8.  Immunochemical analysis by slot blot of ferritin heavy chain protein in OB of 
young and old mice.  (Top) Anti-ferritin antibody showed linearity (R2 > 0.95) against different 
amounts of ferritin H (FTH1) chain in slot blots. (Bottom) The FTH1 in OB of old mice is 
significantly higher (p < 0.05) than that in OB of young mice. 
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Transcriptional analysis of selected proteins in the aging olfactory bulb 
 In order to gain insight into the mechanism(s) of regulation of the differentially expressed 
proteins, we selected several proteins of known function and of relevance to our study for 
transcriptional analysis; these were Atp5a1, Eno1, Fth1, Mdh1 and Dnm1 as well as Omp using 
real-time RT-PCR analysis (Figure 2.9). The specificity of the PCR reaction was confirmed by 
(a) matching the amplicon melting temperature obtained by dissociation curve analysis to the 
calculated melting temperature (Figure 2.9, insets 1-5) and (b) the presence of a single band of 
correct size on an ethidium bromide-stained 2% agarose gel (Figure 2.5., inset 6). We determined 
that the transcripts for Fth1 were present and significantly (p<0.05) up-regulated 1.1-fold in the 
OB of old mice compared to the young (Table 2.6). This is in concordance with the proteomic 
data. In contrast, the transcripts for Dnm1, Mdh1, Atp5a1 and Eno1, while present, were not 
significantly different between the old and young mouse OBs. As anticipated, Omp mRNA was 
expressed at a much lower level overall in the OB than in OE, and was not differentially 
expressed between old and young mouse OBs (Figure 2.9). 
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Figure 2.9. Relative expression of mRNAs in OB. 
Real time RT-PCR data for five of the proteins identified in the proteomic analysis of OB, 
Atp5a1, Fth1, Dnm1, Mdh1, Eno1, as well as Omp, shows the relative amplification of mRNA 
from OB of 3 young and 3 old mice; reactions were done in triplicate. Insets in the first 5 graphs, 
dissociation curve confirming the presence of a unique PCR product; inset in Omp graph shows a 
2% agarose gel electrophoresis of real-time RT-PCR products for Mdh1, Eno1, Dnm1, Fth1, 
Atp5a1 and Omp (lanes 2-7). 
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  Table 2.5. Differentially expressed proteins identified in the OB. 
 
 
 
 
 
 
 
Spot no. Identified proteins Accession no.
Mowse 
Score
% 
sequence 
coverage
No. of 
peptide 
match MrW pI
604 ATP synthase isoform 1 gi|6680748 88 19 10 59.8 9.22
3802 dynamin-1 gi|32172431 124 19 18 98.1 7.61
4503 enolase 1 gi|12963491 86 25 10 47.4 6.37
5104 ferritin heavy chain gi|6753912 82 37 7 21.2 5.53
5302 malate dehydrogenase 1, NAD (soluble) gi|37589957 61 15 7 36.7 6.16
7206 tropomyosin alpha 3 chain gi|111212 95 31 12 29.2 4.75
Proteins were trypsinized and analyzed by Mass Spectrometry in order to ascertain 
their identities. Proteins with a Mowse score ≥ 61 were considered to be identified at 
a statistically significant level. Shaded cells, less abundant proteins in old vs. young 
OB; MrW, molecular weight; pI, isoelectric pH. 
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Table 2.6.  Comparison of results of real time RT-PCR and proteomics in OB. 
 
 
cDNA from OBs of 3 old mice vs. 3 young mice were analyzed (3 technical replicates per 
mouse); CT, cycle threshold; is expressed as mean ± standard deviation; bold indicates p < 0.05 
and concordance in the directions of fold change of the protein and mRNA; NSD, no significant 
difference. 
Gene name Young Old p -value FC (RNA) FC (Protein)
CT CT Old vs Young Old vs Young
Dnm1 20.5±0.3 20.9±0.4 7.26E-02 NSD 1.7
Mdh1 21.9±0.4 21.7±0.4 3.17E-01 NSD 1.9
Eno1 20.8±0.5 21.0±0.5 3.38E-01 NSD 2.3?
Fth1 21.1±0.3 20.7±0.4 2.65E-02 1.1 2.4? 
Atp5a1 20.7±0.4 21.0±0.5 7.42E-02 NSD 1.9
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Discussion 
 
 Studies from our laboratory have led to the successful identification of brain proteins 
using a strategy based on 2D separation of proteins in models of brain aging (Poon et al. 2004b) 
and in Alzheimer’s disease (Butterfield 2004; Butterfield and Boyd-Kimball 2004; Butterfield et 
al. 2003; Castegna et al. 2002a; Castegna et al. 2002b; Castegna et al. 2003) and models thereof 
(Boyd-Kimball et al. 2005a; Boyd-Kimball et al. 2005b), Parkinson’s disease (Poon et al. 
2005a), ALS (Perluigi et al. 2005), and HIV dementia (Pocernich et al. 2005). In the current 
study, 9 proteins in the OE and 20 proteins in the OB were differentially expressed in young and 
old mice.  The number of differentially expressed proteins is in concordance with a previous 
study on aging brain using 2D gel electrophoresis in which Chen et al. determined that 5 proteins 
were differentially expressed in aging human brain (Chen et al. 2003).  Some proteins, including 
those with a high isoelectric point and low abundance, may pose a challenge in the use of 2D 
gels as a protein separation strategy (Butterfield et al. 2003).   
 We report in this study that proteomic changes occur in the aging murine OE and OB and 
have identified the proteins that were regulated at the transcriptional level. Upon examination of 
the proteomic data, we observed that the proteins that were differentially expressed in the aging 
OE and OB fell into three broadly-defined functional groups, with some placed in more than one 
of these groups: namely, metabolism (primarily mitochondrial metabolism); transport/motility; 
and stress response (Figure 2.10). Interestingly, these processes are known to be affected in 
aging (Ames et al. 1993; Poon et al. 2004a; Toescu et al. 2004; Zecca et al. 2004). 
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Figure 2.10. Venn diagram showing the functional relationships of the proteins which were 
expressed at significantly different levels in the aging murine OE and OB. 
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Metabolism 
 Of the proteins involved in metabolism, ACO2, ALDH2, ATP5A1 and MDH1 are 
mitochondrial enzymes, while ALDO1 and ENO1 are cytosolic. ACO2, a mitochondrial matrix 
enzyme involved in the Kreb’s cycle, was found to be up-regulated in the OE of old mice as 
compared to the young mice. ACO2 is a known selective target of oxidation during 
aging/oxidative stress (Sastre et al. 2003) and is also known to be specifically inhibited by 
peroxynitrite, leading to mitochondrial dysfunction (Radi et al. 2002a). The up-regulation of 
ACO2 seen here in the OE of old mice may be a result of an accumulation of inactive enzyme 
that may be either oxidized, nitrated or both, resulting in the impairment of mitochondrial 
respiration. Transcriptional up-regulation of Aco2 with aging may be a cellular response to 
oxidative stress for compensation for this lack of active enzyme.  
 ALDH2, also a mitochondrial enzyme, was down-regulated in the OE of old mice. This 
enzyme is a known target for oxidation under conditions of oxidative stress (Reverter-Branchat 
et al. 2004) and is thought to be protective against oxidative stress (Ohsawa et al. 2003). Also, 
this enzyme has been associated with age-associated neurodegenerative diseases such as AD. 
The levels of ALDH2 were found to be higher in the cerebral cortex of AD patients (Picklo et al. 
2001), and its deficiency has been associated with an increased risk of AD and elevated oxidative 
stress (Ohta et al. 2004); (Kim et al. 2004). We found the protein levels of this enzyme to be 
down-regulated in the OE of old mice as compared to the young mice. This may result in an 
increased susceptibility to oxidative stress in the OE of old mice.  
 ATP5A1, another mitochondrial protein and a key metabolic/bioenergetic component of 
the cell, was observed to be in greater abundance in the OB of old mice as compared to young. 
ATP5A1 is responsible for proton transport and oxidative phosphorylation as part of the 
mitochondrial electron transport chain as a component of the ATP synthase complex. In a 
microarray study, Atp5a1 was shown to be down-regulated in aging human brains (Lu et al. 
2004). The protein accumulates as a fluorophore in lipofuscin granules in the brains of aging rats 
(Szweda et al. 2003), the cerebral cortex of aging rats (Nicoletti et al. 1998), and the cytosol of 
degenerating neurons in AD brains (Sergeant et al. 2003). Thus, it is possible that in the mouse 
OB, accumulation of ATP5A1 (possibly cytosolic) with aging could lead to a decrease in 
available active mitochondrial ATP5A1, and, consequentially, a decline in mitochondrial ATP 
production. 
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 Another mitochondrial metabolic enzyme that was up-regulated in the OB of old mice 
was MDH1. This protein has been shown to be expressed in the olfactory cortex (Sandberg et al. 
1984). The enzyme is located within the mitochondrial matrix and is involved in the malate-
aspartate shuttle, which is the connecting link between glycolysis and mitochondrial respiration. 
This protein transfers NADH across the mitochondrial membrane to respiratory complex I. The 
up-regulation of MDH1 in the aging OB may be compensatory for reduced activity of ATP 
synthase downstream in the electron transport chain.  
 ALDO1 is a brain-specific glycolytic enzyme that we have shown to be up-regulated in 
the OE of old mice. The gene Aldo1 is highly expressed in the olfactory mucosa (Genter et al. 
2003); (Tietjen et al. 2003) as determined by microarray analysis. Evidence suggests that protein 
levels of glycolytic enzymes, including ALDO1, may be up-regulated during aging in order to 
compensate for the metabolic decline of mitochondrial respiration (Kopsidas et al. 2000). 
ALDO1 is also a target of oxidation under oxidative stress conditions (Reverter-Branchat et al. 
2004) and has been shown to have reduced activity with aging in the rat lens (Bours et al. 1988). 
ENO1, a key glycolytic enzyme and also known as α-enolase (a subunit of brain-specific 
enolase;  (Keller et al. 1994), was up-regulated in the OB of old mice. Our transcriptional 
analysis implies that ENO1 was post-transcriptionally regulated, which may indicate reduced 
proteasomal degradation of this protein as a result of ENO1 possibly being oxidized/nitrated or 
due to decreased activity of the proteasome during aging (Keller et al. 2004). ENO1 is also 
known to be up-regulated at the protein level in AD brains (Schonberger et al. 2001). Under 
conditions of oxidative stress, ENO1 is a specific target of oxidation and is both oxidized and 
nitrated in brains of AD patients (Reverter-Branchat et al. 2004); (Castegna et al. 2002b) 
(Castegna et al. 2003). Interestingly, similar to ALDO1, an up-regulation of this enzyme may be 
part of a glycolytic compensation for mitochondrial metabolic decline in the OB.  
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Transport/Motility and Stress response 
 While recognizing the overlapping transport and/or stress-associated roles of some of the 
metabolic enzymes described above, we have grouped the remaining proteins into these two 
categories based on what appears to be their primary function. 
FTH1, which we showed to be highly up-regulated in the OB of old mice, is a transport protein 
primarily involved in iron homeostasis. We also confirmed this result immunochemically and 
demonstrated that Fth1 is up-regulated at the transcriptional level as well. The gene for Fth1 was 
reported to be expressed in the olfactory sensory nerves (Tietjen et al. 2003), and the protein has 
been localized in oligodendrocytes and astrocytes of various human brain regions (Connor et al. 
1990). Brains of Fth-/- mice show characteristics of increased oxidative stress (Thompson et al. 
2003). Interestingly, both Fth1 and Aco2 mRNAs contain iron-responsive elements (IREs), and 
their translation to protein is regulated by iron levels through the mediation of iron binding 
proteins (Schalinske et al. 1998). Iron (II) promotes lipid and protein oxidation in oxidative stress 
conditions, and the levels of this metal ion have been shown to increase in aging and 
neurodegenerative diseases, with high accumulation in lipofuscin granules (Terman and Brunk 
2004); (Killilea et al. 2004). Thus, FTH1 may be up-regulated in response to elevated oxidative 
stress and may be exerting a protective effect in the aging olfactory system by sequestering the 
increased levels of iron ions.  
 PPIA, also known as cyclophilin A, is an abundant protein of the immunophilin family 
that is the primary target for the immunosuppressant cyclosporin A in humans (Jin et al. 2004). 
Cyclosporin A is a neuroprotector under conditions of ischemic injury and acts via modulation of 
the mitochondrial permeability transition pore dynamics and maintenance of mitochondrial 
homeostasis (Crompton 2004; Sullivan et al. 1999). PPIA is a pro-inflammatory molecule that is 
secreted by macrophages (Jin et al. 2004), among other cells, in response to oxidative stress. The 
known functions of this protein include the activation of NF-κB-mediated inflammatory response 
in endothelial cells (Jin et al. 2004) and chaperone activity under stress in vitro (Ou et al. 2001). 
Ppia is expressed in olfactory sensory neurons as shown by single-cell microarray studies 
(Tietjen et al. 2003). In the OE of old mice, we showed an up-regulation of PPIA protein levels 
that we confirmed by immunochemical analysis. An up-regulation of PPIA  suggests a response 
to increased oxidative stress in the aging OE which would aid in protection via its chaperone 
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activity and/or may be functioning in an anti-apoptotic manner. ENO1, which was described 
above under metabolism, also has chaperone activity (Pancholi 2001). 
 TPM3, another protein that was up-regulated in old OB, is an actin-binding protein. 
TPM3 undergoes iron (II)-mediated oxidation under oxidative stress that targets this protein for 
proteasomal degradation (Drake et al. 2002). Altered levels of TPM3 may affect 
anterograde/retrograde transport in the olfactory neurons and/or mitochondrial movement 
leading to nerve ending loss in aging mice.  
 DNM1, a protein involved in cellular motor activity and receptor-mediated endocytosis, 
has been localized in the olfactory system. The protein is co-localized with clathrin in cell 
bodies, dendrites and dendritic knobs of olfactory receptor neurons (Rankin et al. 1999).  DNM1 
has been shown to be expressed in rat OB where it forms a stable complex with synaptojanin-1 
and endophilin3 (ENDO3), an inhibitor of clathrin-mediated endocytosis that co-localizes with 
dopamine D2R receptors at the synaptic termini of olfactory sensory neurons (Sugiura et al. 
2004); (Faire et al. 1992). At the transcriptional level, Dnm1l was observed to be down-regulated 
in the aging human brain (Lu et al. 2004). Here, we have shown that DNM1 protein is down-
regulated in the OB of old mice, suggesting altered neurotransmitter reuptake by olfactory 
neuronal synapses with aging. 
 Our results are the first demonstration of proteomic changes occurring in the normally 
aging olfactory system. These alterations in the protein profile of the aging olfactory epithelium 
and olfactory bulb are specific to the pathways involving mitochondrial and cytosolic 
metabolism, intracellular transport and altered response to stress. Our transcriptional analysis 
begins to identify the mechanisms of regulation of these proteins in the aging olfactory system. 
Our results on differences in the proteins and associated mRNAs in the OE and OB of old and 
young mice may provide insight into changes in the olfactory system in aging and in age-related 
neurodegenerative disorders. 
43 
CHAPTER THREE 
 
OXIDATIVE STRESS IN THE AGING MURINE OLFACTORY BULB:  REDOX 
PROTEOMICS AND CELLULAR LOCALIZATION 
 
Radhika A. Vaishnav,1 Marilyn L. Getchell,2,3 H. Fai Poon,4 Kara R. Barnett,2 Samuel A. 
Hunter,1 William M. Pierce,6 Jon B. Klein, 7, D. Allan Butterfield,3,4,5 Thomas V. Getchell,1,3 
 
1Department of Physiology, 2Department of Anatomy and Neurobiology, 3Sanders Brown Center 
on Aging,  4 Department of Chemistry, and 5Center of Membrane Sciences, University of 
Kentucky, Lexington, Kentucky, USA and 6Department of Pharmacology and 7Core Proteomics 
Laboratory, University of Louisville, Louisville, KY, USA 
 
J.  Neurosci. Res. 2007 Feb 1;85(2):373-85. 
 
Note: In the Results section of Chapter Three, I, Radhika Vaishnav, contributed 100% to the 
research shown in Figures 3.1, 3.2, 3.3, 3.4, 3.5; 90% to the research shown in Figure 3.7 and 
3.8; 80% to the research shown in Figure 3.9; and 50% to the research shown in Figure 3.6. 
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Introduction 
 
 Olfactory sensory decline is associated with aging and age-related neurodegenerative 
disorders including Alzheimer’s and Parkinson’s diseases (Doty 1991a; Murphy et al. 2002), yet 
researchers are only beginning to understand the basic molecular and cellular mechanisms 
underlying age-associated olfactory dysfunction.  In addition to the many neuroanatomical and 
immunohistochemical changes that have been documented in the olfactory epithelium (OE) and 
olfactory bulbs (OBs) of aging humans (Kovacs 2004), several studies have suggested that 
increased oxidative stress occurs in the olfactory system of elderly humans.  Results from our 
laboratory demonstrated age-related reductions in the levels of glutathione-related and 
antioxidant enzymes in the OE (Krishna et al. 1995) and in HSP70 expression in human 
olfactory sensory neurons (Getchell et al. 1995).  In the OBs of elderly humans, high levels of 
lipofuscin, a pigment that represents the intralysosomal accumulation of undegradable 
oxidatively modified molecules (Terman and Brunk, 2006), as well as numerous microglia, 
which generate free radicals, were observed (Getchell 2002); Getchell et al., 2001).  
Additionally, in senescence-accelerated mice, an animal model of aging, oxidative stress-
associated gene expression was up-regulated in the OE (Getchell et al. 2004; Getchell et al. 
2003d). 
 Oxidative stress is a major mediator of the progressive decline in cellular function during 
aging in various tissues.  In the aging brain, free radical-mediated oxidative stress results in the 
oxidation of proteins, nucleic acids, and lipids, altering the structure and function of these 
macromolecules (Beckman and Ames 1998).  Increased protein oxidation has been associated 
with reduced enzyme activity leading to cellular dysfunction in aging as well as in age-related 
neurodegenerative diseases (Butterfield and Stadtman 1997; Dalle-Donne et al. 2006)a).  
Interestingly, not all proteins are oxidized, and many enzymes preserve their activity during 
aging, suggesting that specific proteins are targets of oxidative modification during aging and in 
age-related neurodegenerative disorders (Butterfield et al. 2003). 
In a previous proteomics study, we investigated the steady state levels of proteins in the OBs of 
1.5- and 20-month old mice and reported that 20 proteins were expressed at significantly 
different levels at the 2 ages (Poon et al. 2005b).  Six of these proteins were identified and were 
associated with functions related to oxidative stress, metabolism including mitochondrial 
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metabolism, and transport.  One, ferritin heavy chain (FTH), was differentially regulated at the 
transcriptional level as well.  Several of these proteins have been previously identified as specific 
targets of oxidation in aging and/or oxidative stress in other systems (Radi et al. 2002b; Sastre et 
al. 2003). 
 The aim of the current study was to determine if elevated oxidative stress as indicated by 
the level of protein oxidation occurs in the murine OB.  I investigated two forms of protein 
oxidation:  carbonylation and nitration.  I used redox proteomics to evaluate protein 
carbonylation, measuring total levels of protein oxidation and identifying several oxidized 
proteins, and immunohistochemistry to evaluate protein nitration and its cellular localization.  
Our results demonstrate that:  1) both total protein carbonylation and nitration are elevated in the 
OBs as a function of age; 2) specific proteins that we have identified are targets of carbonylation; 
3) localization of 2 targets of protein oxidation are localized in neuronal and glial cell types that 
perform key roles in olfactory sensory processing and cellular homeostasis;  and 4) protein 
nitration targets primarily the vasculature of the OB.  These results provide the first proteomics 
study that demonstrates molecular targets of and mechanisms by which protein oxidation could 
impact olfactory function during aging. 
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Materials and methods  
 
Animals 
 A total of eighteen C57BL/6 male mice, obtained from Harlan, USA were used for this 
study; eight, from the National Institute on Aging Aged Rodent Colonies, were 20 months old, 
three were 6 months old, and seven were 1.5 months old.  At 1.5 months of age, mice are 
sexually mature, so “young adult” could also be used to describe these mice.  The mice were 
maintained in an animal facility at the University of Kentucky Department of Laboratory Animal 
Research on a 12 hr light:dark cycle in Bioclean units with sterile-filtered air and provided food 
and water ad libitum.  All protocols were implemented in accordance with NIH guidelines and 
approved by the University of Kentucky Institutional Animal Care and Use Committee.  The 
body weights of the 1.5 month-old mice ranged from 19 to 24 g, those of the 6-month old mice 
from 25 to 32 g, and those of the 20-month old mice from 32 to 35 g.  For protein analysis, 
following euthanasia with CO2, the OBs from four 1.5-month old and five 20-month old mice 
were removed quickly, weighed and snap frozen in liquid N2.  For histology, three 1.5-month 
old, three 6-month old, and three 20-month old mice were perfused with 3% paraformaldehyde 
followed by tissue processing and sectioning (coronal) as previously described (Kwong et al. 
2004). 
 
Sample Preparation 
 The OB samples were homogenized in a lysis buffer (10 mM HEPES, 137 mM NaCl, 4.6 
mM KCl, 1.1 mM KH2PO4, 0.6 mM MgSO4) containing the protease inhibitors leupeptin (0.5 
mg/mL), pepstatin (0.7 µg/mL), trypsin inhibitor (0.5 µg/mL), and PMSF (40 µg/mL).  
Homogenates were centrifuged at 15,800 g for 10 min to remove debris.  The supernatant was 
extracted to determine the total protein concentration by the BCA method (Pierce, Rockford, IL). 
 
Immunochemical Detection of Total Protein Carbonyl Levels 
 Slot blots were used to detect the level of total protein carbonylation in the OBs of young 
and old mice as previously described (Poon et al. 2005b).  Briefly, protein carbonyls in 
homogenates from the OBs of the four young and five old mice were derivatized by 10 mM 2,4-
dinitrophenylhydrazine (DNPH) to form the hydrazone (DNP).  To determine carbonyl levels, 
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250 ng of DNP-protein adducts were loaded into each slot.  The technique for the 
immunochemical detection of the DNP-protein adducts was described previously (Poon et al. 
2005b). 
 
Two-dimensional gel electrophoresis 
 Tissue homogenates containing 200 μg of protein from the OBs of 4 1.5-month old and 5 
20-month old mice were each applied to nine pH 3-10 ReadyStrip™ IPG strips (Bio-Rad, 
Hercules, CA) for isoelectric focusing (IEF).  After focusing, the IEF strips were stored at –80oC 
until second dimension electrophoresis was performed.  For second dimension electrophoresis, 
nine Linear Gradient (8-16%) Precast criterion Tris-HCl gels (Bio-Rad) were used to separate 
proteins according to their molecular weight (MrW) after IEF.  Precision ProteinTM Standards 
(Bio-Rad) were run along with the samples.  After electrophoresis, the 9 separate gels were 
incubated in fixing solution for 20 min.  The gels were stained with SYPRO Ruby for 2 hr, after 
which the gels were placed in deionized water overnight for destaining. 
 
Western Blotting 
 Western blotting of the 2D gels was performed as previously described (Poon et al. 
2005b).  Two hundred μg of protein from each of the four 1.5-month old and five 20-month old 
mice were incubated with 10 mM DNPH solution (in 2N HCl) at room temperature for 20 min.  
The gels were prepared in the same manner as for 2D electrophoresis as described above.  The 
proteins from the 2D electrophoresis gels were transferred onto nitrocellulose paper using a 
Transblot-Blot® SD semi-Dry Transfer Cell (Bio-Rad) at 15V for 2 hr.  The DNP adducts of the 
carbonyls of the OB proteins were detected immunochemically as described above. 
 
Image Analysis and Statistics 
 The gels and nitrocellulose blots were scanned and saved in TIF format using a Storm 
860 Scanner (Molecular Dynamics) and a Scanjet 3300C (Hewlett Packard), respectively.  
PDQuest software (Bio-Rad) was used for matching and analysis of visualized protein spots 
among the different gels and oxyblots.  The principles of measuring intensity values by 2D 
analysis software are similar to those of densitometric measurement.  The average mode of 
background subtraction was used to normalize intensity values, which represent the amount of 
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protein (total protein on gel or oxidized protein on oxyblot) per spot.  After completion of spot 
matching, data analysis was performed as follows:  to compare the relative amounts of each 
matched protein in the 4 individual SYPRO Ruby stained gels from 1.5-month old mice and the 
5 individual SYPRO Ruby stained gels from the 20-month old mice, Student’s t-tests were 
performed on the average normalized intensity for each spot.  Similarly, to compare the 
differences in protein-bound carbonyls for each matched spot, Student’s t-tests were performed 
on the average normalized intensity from the 4 individual oxyblots from the 1.5-month old mice 
and the 5 individual oxyblots from the 20-month old mice.  The degree of carbonylation, a 
measure of specific protein oxidation, was determined for each matched spot in each age group 
by dividing the intensity of the protein carbonyl spot on the oxyblots by the intensity of the 
protein spot on the SYPRO Ruby stained gel.  To compare the degree of carbonylation for each 
matched spot, Student’s t-tests were performed on these ratios.  Similar statistical analyses are 
routinely used for proteomics data analysis (Korolainen et al., 2002; Maurer et al., 2005, Huang 
and Li, 2006; Poon et al., 2006a)(Boyd-Kimball et al. 2006; Korolainen et al. 2002; Maurer et al. 
2005).  Three spots that had statistically different degrees of carbonylation (p-values < 0.05) and 
one spot that showed a significant difference in protein-bound carbonyls and a trend toward a 
significant difference in the degree of carbonylation (p = 0.06) in the OBs of 20- vs. 1.5-month 
old mice were selected for identification by MS. 
 
Trypsin digestion 
 Samples were digested using the techniques previously described (Poon et al. 2005b).  
Briefly, the selected protein spots, chosen by PDQuest imaging software (Bio-Rad) as being 
different between young and old mice, were excised and washed with ammonium bicarbonate 
(NH4HCO3), followed by acetonitrile at room temperature.  The protein spots were incubated 
with dithiothreitol, and then iodoacetamide solutions.  The gel pieces were digested with 20 ng/µl 
modified trypsin (Promega, Madison, WI) using 25 mM NH4HCO3 with the minimum volume to 
cover the gel pieces.  The gel pieces were chopped into smaller pieces and incubated at 37°C 
overnight in a shaking incubator. 
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Mass Spectrometry (MS) and Protein Identification 
 Digests (1 μL) were mixed with 1 μL α-cyano-4-hydroxy-trans-cinnamic acid (10 
mg/mL in 0.1% TFA:ACN, 1:1, v/v).  The mixture (1 μL) was deposited onto a fast evaporation 
nitrocellulose matrix surface, washed twice with 2 μL 5% formic acid, and analyzed with a 
TofSpec 2E (Micromass, Manchester, UK) MALDI-TOF mass spectrometer in reflectron mode.  
The mass axis was adjusted with trypsin autohydrolysis peaks (m/z 2239.14, 2211.10, or 842.51) 
as lock masses.  The MALDI spectra used for protein identification from tryptic fragments had a 
signal/noise ratio above 10 and were selected by MassLynx software (Waters Corp., Milford, 
MA); the resulting peak lists were checked manually to ensure that the peaks were present in the 
spectrum.  Only the selected peaks were submitted to the MASCOT search engine 
(http://www.matrixscience.com), which searched for matches in the NCBI protein databases.  
Peptide mass fingerprinting used the assumption that peptides are monoisotopic, oxidized at 
methionine residues and carbamidomethylated at cysteine residues.  Up to 1 missed trypsin 
cleavage was allowed.  Mass tolerance of 100 ppm was the window of error allowed for 
matching the peptide mass values.  Proteins were identified based on database-matching, with a 
MOWSE score of > 62 considered as significant, as well as on the correspondence between the 
expected and experimental isoelectric points (pIs) and molecular weights (MWs). 
 
Histology and immunohistochemistry  
 To visualize the histological organization of the OB, defatted, rehydrated frozen sections 
were stained with 1% aqueous cresyl violet (Sigma) solution.  To evaluate the amount of 
autofluorescent lipofuscin, sections were rehydrated in PBS, coverslipped, and examined through 
the FITC filter.  For immunohistochemistry, standard indirect immunofluorescence techniques 
were used as previously described (Kwong et al. 2004) to localize 2 proteins that were identified  
by proteomics (ALDO1 and FTH), to identify specific cell types, to evaluate co-localization 
[glial fibrillary acidic protein (GFAP) for astrocytes; CD68 and F4/80 for microglia], and to 
evaluate and localize sites of nitration [3-nitrotyrosine (3-NT) immunoreactivity].  Sections were 
incubated with primary antibodies overnight at 4°C; all secondary antibodies were from Jackson 
ImmunoResearch Laboratories (West Grove, PA).  For aldolase 1 (ALDO1), a goat polyclonal 
antibody (Santa Cruz Biotechnology, Santa Cruz, CA) was used at a 1:50 dilution; the secondary 
antibody was FITC-conjugated anti-goat IgG used at a dilution of 1:100.  Rabbit anti-ferritin 
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heavy chain (FTH) polyclonal antibody (Alpha Diagnostics, San Antonio, TX) was used at a 
dilution of 1:100; FITC-conjugated anti-rabbit IgG was used at 1:100 for immunological 
detection.  Mouse polyclonal anti-GFAP (Chemicon Intl., Temecula, CA) was diluted to 1:2500; 
immunoreactivity was visualized with rhodamine red X-conjugated anti-mouse IgG at a dilution 
of 1:200.  Rat anti-rat monoclonal anti-CD68 (Serotec, Raleigh, NC) and F4/80 (Caltag 
Laboratories/Invitrogen, Carlsbad, CA) were diluted to 1:50; immunoreactivity was visualized 
with rhodamine red X-conjugated anti-rat IgG at a dilution of 1:200.  Rabbit polyclonal anti-3- 
NT (Upstate Cell Signaling Technology, Inc., Danvers, MA) was used at a 1:100 dilution; 
immunoreactivity was visualized using FITC-conjugated anti-rabbit IgG at 1:100.  Coverslips 
were mounted with Vectashield mounting medium with DAPI to visualize nuclei (Vector 
Laboratories, Burlingame, CA). 
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Results  
 
Measurement of total protein carbonylation and identification of differentially carbonylated 
proteins 
 To determine whether there was an increase in protein oxidation in the OBs of 20-month 
vs. 1.5-month old mice, protein-bound carbonyls were derivatized with DNPH and relative 
protein carbonylation was then measured immunochemically using the slot blot technique.  Total 
protein carbonylation was significantly elevated by 17% in OBs of 20-month vs. 1.5-month old 
mice (Figure 3.1).  We utilized a two-dimensional (2D) gel electrophoresis/MS-based redox 
proteomics approach (Dalle-Donne 2006) to identify proteins differentially oxidized in the OBs 
of 20- vs. 1.5-month old mice (flowchart, Figure 3.2).  Briefly, 2D gels and oxyblots were 
prepared as described above, and carbonylated protein spots were evaluated densitometrically for 
the 4 1.5-month and 5 20-month old individual mice.  PDQuest software analysis identified a 
total of 431 protein spots on the SYPRO Ruby red-stained 2D gels and 360 oxidized proteins on 
the 2D oxyblots and matched 164 spots on the oxyblots to corresponding spots on SYPRO Ruby 
red stained gels.  Representative 2D gels and oxyblots of OBs from 1.5- and 20-month old mice 
are shown in Figure 3.3.  The degree of carbonylation (intensity of spot on oxyblot/intensity of 
spot on protein gel) increased for 104 proteins, decreased for 49 proteins, and was unchanged for 
11 proteins in the OBs of 20-month vs. 1.5-month old mice.  Three spots, numbers 306, 4606 and 
5607, exhibited significantly different degrees of oxidation in the OBs of 20- vs. 1.5-month old 
mice, and one spot, number 3202, showed a significant difference in protein-bound carbonyls 
and a trend toward a significant difference (p = 0.06) in the degree of oxidation (Figure 3.4).  
These 4 spots, whose localization on a representative SYPRO ruby-stained 2D gel is shown in 
Figure 3.5, were selected for identification by MS and peptide mass fingerprinting.  The proteins 
were identified as aldolase 1 (ALDO1/ALDOA, spot 306; representative MS analysis shown in 
Figure 3.6), dihydropyrimidinase-like 2 (DPYSL2/DRP2, spot 4606); and heat shock protein 9A 
(HSPA9A, spot 5607; Table 3.1).  For spot 3202, two possibilities were identified but with low 
MOWSE scores (21 and 19) and will not be considered further.  ALDO1 showed an increased 
level of protein-bound carbonyls in 20- vs. 1.5-month old mice, and HSPA9A and DPYSL2 
showed apparent decreases, with the corresponding degree of oxidation following a similar 
pattern. 
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Figure 3.1.  Total protein carbonylation in olfactory bulbs (OBs) from 1.5- and 20-month old 
mice.  Histogram shows a significant increase (17%) in total protein carbonylation in OBs of 20- 
vs. 1.5-month old mice as determined by densitometric analysis of slot blots.  AU, arbitrary 
densitometric units.  *, p < 0.05; error bars, standard error. 
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Figure 3.2.  Flowchart summarizing experimental design and results of redox proteomics.  See 
text for details.  2D, 2-dimensional; DNPH, 2,4-dinitrophenylhydrazine; MS, mass spectrometry.
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Figure 3.3.  Representative two-dimensional gels and corresponding oxyblots of olfactory bulb 
(OB) proteins from 1.5- and 20-month old mice.  Left, SYPRO Ruby-stained 2-dimensional (2D) 
gels for total protein from the OBs of a 1.5-month old mouse (top) and a 20-month old mouse 
(bottom).  Right, oxyblots to detect protein carbonylation in proteins from OBs of the same mice.  
DNPH, 2,4-dinitrophenylhydrazine. 
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Figure 3.4.  Relative carbonylation levels of specific protein spots in OBs of 1.5- and 20-month 
old mice.  Histograms show the relative amount of protein in arbitrary densitometric units (y 
axis) from SYPRO Ruby-stained 2D gels (left column), the relative amount of protein-bound 
carbonyls in arbitrary densitometric units (y axis) in the matched spot on the 2D oxyblots (center 
column), and the degree of oxidation (ratio of amount of protein-bound carbonyls to amount of 
protein, right column).  *, p < 0.05; error bars, standard error. 
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Figure 3.5.  Representative two-dimensional gel of total protein from olfactory bulb (OB) of a 
1.5-month old mouse stained with SYPRO Ruby.  The circled spots correspond to the proteins 
selected for identification based on their differential oxidation in the oxyblots. 
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Figure 3.6.  Representative mass spectrometric identification of aldolase 1 (ALDO1).  (Top) 
MALDI mass spectrum for spot # 306 is shown.  (Bottom) MASCOT-based peptide mass 
fingerprinting identified protein as ALDO1. 
58 
Table 3.1.  Differentially oxidized proteins identified by proteomic analysis 
Spot # Protein 
Protein 
Symbol 
MOWSE
Score 
Coverage 
MW 
(kDa) 
pI 
306 aldolase 1 ALDO1 102 34% 73.8 8.55 
4606 
dihydropyrimidinase-
like 2 
DPYSL2 42* 13% 62.6 5.95 
5607 heat shock protein 9A HSPA9A 59* 16% 73.8 5.91 
Shaded cells, increased specific protein carbonylation in OBs of 20- vs. 1.5-month old mice; 
unshaded cells, decreased specific carbonylation.  *, MOWSE score < 62 is not significant, 
but MW and pI correspond to protein spot. 
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Protein carbonylation status of previously identified proteins 
 Using proteomics, we previously reported the significant up- or down-regulation of 
steady state levels of 20 proteins in the OBs of 20-month vs. 1.5-month old mice (Poon et al. 
2005b).  To determine if any of these proteins or others identified in this study were oxidized, I 
determined the levels of protein-bound carbonyls for each.  This was done by matching the 
SYPRO-stained 2D-gel spots for these previously identified proteins to corresponding spots on 
the newly-generated oxyblots.  The results are summarized in Table 3.2.  Among 15 proteins 
whose steady-state levels were previously shown to be up-regulated, 9 proteins were 
carbonylated, although the degree of carbonylation in 20-month vs. 1.5-month old mice was not 
significantly different for any of them.  Carbonylated proteins whose steady-state levels were up-
regulated included 2 identified in our previous study, ATP synthase isoform 1 (ATP5A1) and 
ferritin heavy chain (FTH), and 1 newly-identified protein, calpain 12 (CAPN12, spot 4204), as 
were unidentified spots 1501 and 6106.  Proteins whose steady-state levels were previously 
shown to be down-regulated included 1 identified in the previous study, dynamin-1 (DNM1), 
and 2 newly-identified proteins , G protein coupled receptor 135 (GPR135, spot number 504) 
and spermatogenesis-associated protein 2 (SPATA, spot number 2704).  In addition, 3 proteins 
whose steady-state levels were not significantly different in 1.5-month vs. 20-month old mice but 
were carbonylated were identified as multimerin 1 (MMRN1, spot number 5101), valosin-
containing protein (VCP, spot number 6704), and retinaldehyde binding protein 1 (RLBP1, spot 
number 6805).  CALPN12 and RLBP1 were carbonylated on oxyblots from 20-month old mice 
only, while the remainder were carbonylated on oxyblots from both 1.5-month and 20-month old 
mice.  In addition, 5 proteins whose steady-state levels were significantly up-regulated in 20- vs. 
1.5-month old mice were not detectably carbonylated; they were RAS-related protein RAB14 
(RAB14), heat shock 70 kDa protein 8 (HSPA8), enolase 1 (ENO1), malate dehydrogenase 
(MDH1), and tropomyosin α3 chain (TPM3). 
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Table 3.2.  Carbonylation status of proteins with previously determined relative steady-state 
levels in OBs of old vs. young mice 
FC, fold change in steady-state protein level in the OB of 20- vs. 1.5-month old mice (Poon 
and Vaishnav et al., 2005); NSD, no significant difference in steady-state protein level.   
*, MOWSE score < 62 is not significant, but MW and pI of spot correspond to 
corresponding protein; **, proteins newly identified from Poon and Vaishnav et al. 2005a.  
Shaded cells, carbonylated proteins observed in oxyblots from 20-month old mice only; 
other carbonylated proteins observed in oxyblots from both 1.5- and 20-month old mice. 
Spot 
# Protein Symbol 
MOWSE 
score 
Coverage 
(%) 
FC 
(steady-
state 
level) 
MW 
(kDa) pI 
Carbonylated proteins 
504 G protein coupled receptor 135** GPR135 45* 8 ↓2.3 50.2 10 
604 ATP synthase isoform 1 ATP5A1 88 19 ↑1.9 59.8 9.2 
2704 
spermatogenesis-
associated protein 
2** 
SPATA2 44* 9 ↓2.6 58.7 8.9 
3802 dynamin 1 DNM1 124 19 ↓1.8 98.1 7.6 
4204 calpain 12** CAPN12 46* 16 ↑1.6 52 6.1 
5101 multimerin 1** MMRN1 65 14 NSD 137.1 7.7 
5104 ferritin heavy chain FTH 82 37 ↑1.9 21.2 5.5 
6704 
valosin-
containing 
protein** 
VCP 206 33 NSD 89.9 5.1 
6805 
retinaldehyde 
binding protein 
1** 
RLBP1 142 48 NSD 36.7 5.0 
Proteins not detectably carbonylated 
110 RAS-related protein RAB14 RAB14 63 33 ↑7.0 24.1 5.9 
1304 heat shock 70 kDa protein 8 HSPA8 199 48 ↑2.3 71.1 5.4 
4503 enolase 1 ENO1 85 25 ↑2.4 47.7 6.4 
5302 
malate 
dehydrogenase 1, 
NAD (soluble) 
MDH1 61* 15 ↑1.5 36.7 6.2 
7206 tropomyosin α3 chain TPM3 95 31 ↑1.9 29.2 4.8 
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Protein nitration 
 To determine whether elevated oxidative stress resulted also in protein nitration in the 
OB, we investigated the presence, relative intensity, and localization of immunoreactivity for 
protein-bound 3-NT in the OBs of 1.5-month, 6-month, and 20-month old mice (Figure 3.7).  In 
1.5-month old mice (Figure 3.7A), faint and diffuse 3-NT immunoreactivity occurred primarily 
in the external plexiform layer with localization in an occasional blood vessel.  In 6-month old 
mice (Figure 3.7B), immunostaining for 3-NT increased, with stronger staining in blood vessels 
as well as staining around the rims of lipofuscin (gold/orange)-containing microglia.  The 
strongest and most abundant staining was observed in 20-month old mice (Figure 3.7C); 
numerous blood vessels and microglia (identified by staining adjacent sections for CD68, not 
shown) in all layers of the OB were intensely immunoreactive for 3-NT. 
 
Immunohistochemical localization of ALDO1 and FTH 
 Because ALDO1, a key glycolytic enzyme, showed a significant elevation in its degree of 
carbonylation in OBs of 20- vs. 1.5-month old mice, we determined its cellular localization using 
immunohistochemistry (Figure 3.8) to identify the cell type(s) that might be affected by the 
potential impairment of its function.  Immunoreactivity for ALDO1 was localized in stellate cells 
(Figure 3.8A) primarily in the granule cell layer of the OB in 1.5-month old mice.  A similar 
intensity and distribution of staining was observed in 20-month old mice (not shown), 
suggesting, as did our previous proteomics analysis, that there were no apparent differences in its 
steady-state level at these ages.  To identify the cell type(s) expressing ALDO1, we double-
stained for ALDO1 (Figure 3.8A) and GFAP (Figure 3.8B), an astrocytic marker.  ALDO1 was 
co-localized with GFAP in numerous astrocytes (Figure 3.8C) in the granule cell layer.  ALDO1 
did not colocalize with CD68 or with F4/80, microglial markers, both of which stained cells 
restricted to the glomerular layer (not shown).  This confirmed the astrocyte-specific expression 
of ALDO1 primarily in the granule cell layer of the OB. 
  
62 
 
 
Figure 3.7.  Localization of 3-nitrotyrosine (3-NT) immunoreactivity in the olfactory bulbs 
(OBs) of 1.5-, 6-, and 20-month old mice.  (A)  In 1.5-month old mice, very faint 3-NT 
immunoreactivity is localized in an occasional blood vessel (arrow).  (B)  In 6-month old mice, 
immunoreactivity in blood vessels is stronger (arrow), and immunoreactive microglia are also 
observed.  (C)  In 20-month old mice, intense immunofluorescence for 3-NT (arrows) is 
localized in blood vessels as well as in microglia throughout the OB.  Sections are counterstained 
with DAPI (blue, nuclear stain) to show the laminar organization of the OB.  GL, glomerular 
layer; EPL, external plexiform layer; MCL, mitral/tufted cell layer; IPL, internal plexiform layer; 
GCL, granule cell layer.  Calibration bar, 50μm. 
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Figure 3.8.  Localization of aldolase 1 (ALDO1) immunoreactivity in astrocytes of the olfactory 
bulb (OB).  (A)  Immunoreactivity for ALDO1 (green) occurs primarily in stellate cells of the 
granule cell layer.  (B)  Identification of astrocytes in the same region is shown by 
immunofluorescence for glial fibrillary acidic protein (GFAP, red).  (C)  ALDO1 and GFAP are 
co-localized (yellow) in numerous astrocytes.  Arrows, representative cell showing positive 
immunoreactivity for both antigens.  Calibration bar, 25 μm. 
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 Because of its known involvement in aging and oxidative stress in the brain and its 
increased level of expression as well as its carbonylation in the OB of 20-month old mice, we 
also selected the iron-management protein FTH for cellular localization (Figure 3.9).  FTH was 
localized in a punctate pattern primarily in mitral/tufted cells in 1.5-, 6-, and 20-month old mice 
(Figs. 3.9A, D, and G, respectively), as can be seen by comparison with adjacent cresyl violet-
stained sections (Figure 3.9B, E, and H).  Qualitatively, mitral/tufted cells contained the least 
immunoreactivity for FTH in the 1.5-month old mice, an intermediate level in the 6-month old 
mice, and the greatest in the 20-month old mice, indicating higher levels of the protein per cell in 
the oldest mice, confirming our previous results on its steady-state levels.  Less abundant 
punctate staining was also observed in periglomerular cells (not shown), with the intensity 
appearing to increase slightly with age.  Also evident were autofluorescent (gold) lipofuscin 
granules, which were almost undetectable in the mitral cell layer in the 1.5-month old mice 
(Figure 3.9C), present in the 6-month old mice (Figure 3.9F), and most abundant in the 20-month 
old mice (Figure 3.9I).  Large amounts of lipofuscin were also observed in the glomerular and 
granule cell layers of the OB (not shown), with its abundance increasing with age as shown in 
the mitral/tufted cell layer. 
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Figure 3.9.  Ferritin heavy chain (FTH) immunolocalization and lipofuscin autofluorescence in 
mitral/tufted cell layer (MCL) of olfactory bulb (OB).  Immunoreactivity for FTH (A, D, G) is 
localized in mitral/tufted cells, shown by cresyl violet staining (B, E, H, arrows) of near-adjacent 
sections from OBs of mice of different ages.  (A)  Sparse punctate FTH immunoreactivity 
(arrow) is localized in mitral/tufted cells in 1.5-month old mice.  (B)  Somewhat more abundant 
punctate FTH immunoreactivity occurs in mitral/tufted cells in 6-month old mice.  (C)  In 20-
month old mice, very intense FTH immunoreactivity (arrow) makes punctate staining appear 
congruent.  Autofluorescent lipofuscin (gold) in the mitral/tufted cell layer also increases in 
abundance, with the least in 1.5-month old mice (C), an intermediate amount in 6-month old 
mice (F), and the most in 20-month old mice (I).  EPL, external plexiform layer; IPL, internal 
plexiform layer.  Calibration bar, 50 μm. 
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 In summary, I have used redox proteomics and immunohistochemistry to investigate the 
age-related oxidation of proteins in the murine OBs.  I have demonstrated that both 
carbonylation and nitration of OB proteins increased with increasing age.  Our results 
demonstrate that there was a significant increase in total protein carbonylation in the OBs of 20- 
vs. 1.5-month old mice, and that specific proteins were targets of carbonylation.  In addition, our 
results indicate that protein nitration contributed to increased protein oxidation in the OBs of 20- 
vs. 6- vs. 1.5-month old mice.  Both forms of protein oxidation occur in identified sites that may 
potentially have major impacts on olfactory function with increasing age. 
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Discussion 
 
 This study has applied a novel approach to olfactory neurobiology, utilizing redox 
proteomics (Dalle-Donne 2006) for the measurement of relative levels of protein carbonylation 
in the murine OB and the identification of proteins that are specific targets of carbonylation.  
Additionally, we used immunohistochemistry for the cellular localization of the proteins targeted 
for carbonylation and for the determination of the relative amounts and localization of targets of 
protein nitration.  This study provides the first results that identify potential mechanisms by 
which oxidative stress resulting in protein oxidation could contribute to age-related olfactory 
dysfunction. 
 The results with redox proteomics documented an increase in total protein carbonylation 
indicative of oxidative stress in the OBs of 20-month compared to 1.5-month old mice.  As 
determined by software analysis, 164 proteins had matching spots on the SYPRO-stained gels 
and the oxyblots; 63% of them showed an increase in carbonylation, 30% showed an apparent 
decrease in carbonylation, and 7% were approximately equally carbonylated in both.  Changes, 
predominantly increases, in protein carbonyl content have been demonstrated in other regions of 
the brains of old mice and rats (Choi et al. 2004; Poon et al. 2006a; Poon et al. 2004b).  The 
degree of oxidation for 3 of the carbonylated proteins changed significantly and that for 1 
additional spot showed a trend toward a significantly different level of carbonylation.  The 3 
proteins with significant differences in carbonylation were identified; this number is comparable 
to the numbers of proteins identified in the studies of aging brain cited above. 
 One of the differentially oxidized proteins was ALDO1, with a 13-fold increase in 
carbonylation in 20- compared to 1.5-month old mice.  This protein has been reported to be a 
specific target of oxidation under conditions of oxidative stress in other tissues as well (Barreiro 
et al. 2005; Koeck et al. 2004; Reverter-Branchat et al. 2004)  ALDO1 associates with the 
mitochondrial outer membrane (Taylor et al. 2003), bringing it into close contact with 
superoxide radicals and peroxynitrite (Koeck et al. 2004) that would facilitate its oxidation.  
Increased carbonylation of ALDO1 has been demonstrated to result in decreased enzyme activity 
(Barreiro et al. 2005); decreases in activity with aging have been observed in rat lens (Bours et 
al. 1988) and mouse liver (Gershon and Gershon 1973).  ALDO1 was localized primarily in a 
sub-set of astrocytes in the granule cell layer of the OB.  The ALDO1-immunoreactive astrocytes 
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do not clearly correspond to any one of the laminar-specific morphological subtypes of 
astrocytes that have been described in the adult OB, although many resemble the semicircular 
form (Chiu and Greer 1996).  Astrocytes play a key role in regulating neuronal synaptic activity 
via glutamate reuptake and de novo synthesis (Fields and Stevens-Graham 2002; Pellerin and 
Magistretti 1994).  The localization of ALDO1, a selective target of oxidative modification in the 
aging OB, in astrocytes in the granule cell layer suggests that glial-neuronal homeostasis in the 
OB may be impaired with aging. 
 The other 2 proteins identified in this study, DPYSL2 and HSPA9A, showed a significant 
decrease in specific carbonyl levels in OBs of 20- vs. 1.5-month old mice.  DPYSL2/DRP2 is a 
member of the dihydropyrimidinase-related protein family.  These proteins are involved in 
axonal outgrowth and neuronal migration.  DRP2 was up-regulated in brains of old mice (Poon 
et al. 2006b) and is a known target of carbonylation in the aging brain (Poon et al. 2004b) and in 
Alzheimer’s disease (Castegna et al. 2002b).  HSPA9A/mortalin/mitochondrial HSP70, an 
HSP70 chaperone family member localized primarily in mitochondria (Kaul et al. 2002), 
performs a key role in basic biological processes such as intracellular protein trafficking, cell 
cycling, and stress response.  The related chaperone HSP70 was localized in mammalian 
olfactory sensory neurons (Carr et al. 1994) and was down-regulated in an age-dependent 
manner (Getchell et al. 1995).  HSPA9A was reported to show an increase in carbonylation in 
brains of old as compared to young mice (Choi et al. 2004).  An apparent decrease in protein 
carbonylation as observed for these two proteins in the OB of 20- vs. 1.5-month old mice may 
result from several mechanisms (Korolainen et al. 2002; Shringarpure and Davies 2000).  The 
oxidized proteins may become cross-linked and accumulate as aggregates, thus removing the 
oxidized protein molecules from the soluble fraction that is assayed by the proteomics 
technology used in our study.  Aggregates of oxidized proteins result in the accumulation of 
lipofuscin (Keller et al. 2004), which we observed in abundance in the OBs of the 20-month 
compared to 1.5-month old mice in this study, suggesting that this mechanism may explain at 
least in part the apparent reduction in oxidation levels of these proteins.  Oxidized proteins may 
also undergo higher rates of synthesis and/or turnover; because we examined only the steady-
state level of oxidized proteins in the OB, a higher rate of turnover of the oxidized proteins may 
also have resulted in apparent decreases in the concentration of the carbonylated proteins. 
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 In our previous study, we used proteomics to identify several proteins whose levels were 
significantly increased or decreased in the OBs of old compared to young mice (Poon et al. 
2005b).  In this study, I determined the carbonylation status of these proteins as well as several 
whose steady-state levels were unchanged but that were carbonylated.  Two proteins that whose 
steady-state levels were significantly up-regulated, ATP5A1 and FTH, were also carbonylated in 
OBs from both 1.5- and 20-month old mice.  DNM1, whose steady-state level was significantly 
down-regulated, was also carbonylated in OBs from both 1.5- and 20-month old mice.  DNM1 
and ATP5A were also found to be targets of protein carbonylation in another study of young vs. 
old mouse brains (Soreghan et al. 2003); DNM1 was shown to be carbonylated in whole brains 
of both young and old mice, while the lipofuscin-related ATP5A1 was carbonylated in the brains 
of young mice only.  Our different results on these proteins in the OB suggest the occurrence of 
regional differences in targets of protein oxidation during brain aging. 
 The expression of FTH, an oxidative stress-response protein that plays a key role in iron 
homeostasis, was significantly increased in the OBs of old mice (Poon et al. 2005b), consistent 
with its increase in other brain regions with aging (Connor et al. 1995);(Zecca et al. 2004).  In 
this study, I demonstrated additionally that FTH immunostaining is most abundant in the 20-
month old, intermediate in the 6-month old, and lowest in the 1.5-month old; that FTH is 
carbonylated in the OBs of 1.5- and 20-month old mice, and that it is localized primarily in 
mitral/tufted cells, the second-order neurons in the transmission of olfactory information to 
higher brain centers.  Our results suggest that mitral/tufted cells are targets of age-related 
oxidative stress that may result in functional deficits in the transmission of olfactory information 
to higher brain centers, contributing to the age-related decline in olfactory function. 
 Two of the previously identified proteins, CAPN12 and RLBP1, were carbonylated in the 
OBs of 20-month old mice only, although differences in protein-bound carbonyls and degree of 
oxidation when compared with OBs from 1.5-month old mice were not significant.  However, 
their oxidation suggests the possibility of functional alterations of their activity in the OBs of the 
older mice.  CAPN12 was identified as a specific target of protein nitration in the cerebral cortex 
of Tg2576 transgenic mice that express high levels of a mutated human β-amyloid precursor 
protein (Shin et al. 2004).  Calpains are Ca2+-activated proteolytic enzymes that have been 
implicated apoptosis in neurons and astrocytes (Raynaud and Marcilhac 2006); an oxidation-
mediated reduction in enzyme activity may contribute to inefficient or incomplete apoptosis of 
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functionally impaired cells.  RLBP1 (CRABP1) has been localized in scattered glomerular and 
granule cells in the murine OB (Rawson and LaMantia 2006), and non-dopaminergic 
periglomerular cells express very high levels of retinoic acid (RA)-synthesizing enzymes 
(Wagner et al. 2002), suggesting that RA modulates neuronal function and maintenance.  
Oxidation of RLBP1 may reduce its ability to modulate RA availability in the OB of 20-month 
old animals, contributing to RA-mediated aging pathology (Rawson and LaMantia 2006). 
 The other proteins whose expression was altered in the old vs. young mice, i.e., RAB14, 
ENO1, TPM3 and MDH1, did not have corresponding spots on any of the 9 oxyblots, indicating 
that they were not detectably carbonylated.  This emphasizes that specific proteins are targets for 
carbonylation and suggests that in the aging OB, steady-state protein levels are regulated by 
mechanisms that differ from those that target specific proteins for oxidative modification, and 
that integration of data from various levels of protein synthesis and modification is necessary to 
fully understand how aging affects these processes. 
 Immunoreactivity for 3-NT is an indicator of protein oxidation mediated by peroxynitrite, 
formed when nitric oxide interacts with superoxide; the resultant free radical reactions result in 
the nitration of tyrosine residues (Radi 2004).  There was a gradation in intensity of 
immunostaining in the OBs of mice at the 3 ages we examined, with the faintest staining in the 
1.5-month olds, intermediate levels in the 6-month olds, and the most intense in 20-month old 
mice.  Staining was localized primarily in the blood vessels and lipofuscin-containing microglia.  
3-NT immunoreactivity was previously demonstrated in endothelial and microglial cells in the 
human OB, primarily in the glomerular layer, of elderly subjects and was elevated in AD patients 
(Getchell 2002; Getchell 2001a).  Nitration as indicated by 3-NT immunoreactivity has been 
associated with vascular dysfunction (Luthra et al. 2005; Maneen et al. 2006; Radi 2004); 
vascular dysfunction in the OB as in other brain areas may lead to imbalances in ionic 
homeostasis (Bailey et al. 2004) with direct effects on neuronal transmission and viability that 
would certainly contribute to impaired olfactory function with aging. 
 I have demonstrated a significant increase in protein oxidation in the OBs of old 
compared to young mice, identified specifically carbonylated proteins and the cells in which the 
proteins are expressed, and identified sites of increased age-related nitration in the murine OB.  
These results strongly support the concept that oxidative stress, which results in oxidative 
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modification of specific proteins in identified cells of the OB, is a major mechanism underlying 
age-associated olfactory dysfunction. 
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Introduction 
 
 Many neurodegenerative diseases lead to olfactory sensory decline, yet the molecular 
mechanisms underlying this process are still unclear and under investigation.  Olfactory 
impairment has been demonstrated to occur with aging in humans (Cerf-Ducastel and Murphy 
2003; Doty et al. 1991) as well as in neurodegenerative disorders such as Alzheimer’s, 
Parkinson’s, and Huntington’s disease (Mesholam et al. 1998a; Nordin et al. 1995).  
Neurodegeneration has been associated with certain molecular and cellular processes that include 
elevated oxidative stress/stress response; macromolecular damage including increased DNA 
damage, protein oxidation, and lipid peroxidation; mitochondrial metabolic decline; apoptosis 
and altered cell cycle dynamics; and increased inflammatory response (Park and Prolla 2005).  
Neurons are particularly sensitive to oxidative stress, which can lead to apoptotic cell death 
(Krantic et al. 2005; Rego and Oliveira 2003).  We have previously shown that oxidative stress 
and associated macromolecular damage is a hallmark of olfactory aging and neurodegeneration 
(Getchell et al. 2003a; Getchell et al. 2003b; Getchell et al. 2003c; Getchell et al. 1995; Krishna 
et al. 1995; Poon et al. 2005b; Vaishnav et al. 2006). 
 The Harlequin mouse, a model of adult-onset neurodegeneration, carries an X-linked 
recessive mutation in the Pdcd8 (programmed cell death 8) gene, the protein product of which is 
known as apoptosis-inducing factor (AIF; (Klein et al. 2002; Susin et al. 1999).  This protein is 
known to have two distinct cellular functions mediated by different molecular domains: first, the 
maintenance of normal mitochondrial metabolism and consequently low levels of oxidative 
stress in neurons via its oxidoreductase domain, and second, the induction of apoptosis in a 
caspase-independent manner via its apoptosis domain.  In the Harlequin mouse, the Hq allele of 
the Pdcd8 gene contains an intronic proviral DNA insertion in the oxidoreductase domain, 
resulting in an 80% reduction in Pdcd8 mRNA and AIF protein expression, increased oxidative 
stress, and mitochondrial bioenergetic impairment in several tissues including the brain (Klein et 
al. 2002).  Interestingly, in the retina and cerebellum of the Harlequin mutant mice, the levels of 
the modified DNA base 8-hydroxydeoxyguanosine (8OHdG) increases in various cell types, 
leading to increased mutations and apoptotic cell death of certain neurons (Klein et al. 2002; 
Stringer et al. 2004; Vahsen et al. 2004).  Harlequin mice exhibit progressive retinal 
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degeneration, beginning with the loss of amacrine and ganglion cells at 3 months of age and 
extending to all layers of the retina by 11 months.  Beginning at 4 months of age, they also 
exhibit cerebellar degeneration, including apoptosis of granule cells, with ataxia appearing at 
around 5 months and progressing with age (Klein et al. 2002). 
 In this study, we investigated whether similar oxidative stress-induced neurodegenerative 
changes occurred in the olfactory system of the Harlequin mutant mouse, which might then serve 
as a model for investigating the mechanisms by which age-associated oxidative stress leads to 
olfactory neurodegeneration.  Our novel cellular results using six-month old male Harlequin 
mutant mice (Hq/Y) and age- and gender-matched littermate controls (+/Y) demonstrated that 
elevated oxidative stress, increased apoptotic cell death, and marked cellular degeneration occur 
in the olfactory epithelium (OE) of the Hq/Y mutant mouse.  Our microarray analyses confirmed 
and extended our cellular analyses to the molecular level, demonstrating a significant reduction 
in the expression of Pdcd8 and the dysregulation of expression of genes in several relevant 
categories, including oxidative stress, apoptosis/cell cycle, cytoskeletal organization, and 
neurogenesis, validating the Harlequin mutant mouse as a model in which to investigate 
underlying mechanisms of oxidative stress-induced olfactory neurodegeneration. 
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Materials and methods 
 
Animal and tissue preparation 
 A total of 12 mice were obtained from Jackson Laboratories (Bar Harbor, ME): six male 
B6CBACa Aw-J/A-Pdcd8-Hq/J (stock number 00501) mutant mice or “Hq/Y” and six 
B6CBACa wild-type littermate controls or “+/Y.”  The mice were purchased at 13 weeks of age 
and were maintained in an animal facility at the University of Kentucky Department of 
Laboratory Animal Research (DLAR) until they reached six months of age.  At the DLAR, they 
were kept on a 12 hr light:dark cycle in Bioclean units with sterile-filtered air and provided food 
and water ad libitum.  All protocols were implemented in accordance with NIH guidelines and 
approved by the University of Kentucky Institutional Animal Care and Use Committee. 
 The six-month old Hq/Y mutant mice were small (mean body weight 26.0 g), moderately 
ataxic, and had patchy to extensive hair loss, primarily on their dorsal side.  The six-month old 
+/Y controls were larger (mean body weight 39.5 g), exhibited a normal gait, and had a thick 
brown coat of fur.  One +/Y mouse died of apparent natural causes as the mice aged in the 
DLAR facility, resulting in a total of 11 mice used in our study.  The number of mice available 
for use in our study was limited by the number that met our strict age, gender and littermate 
inclusion criteria.  
 For histology, two mice per group were injected with 5-bromo-2’-deoxyuridine (BrdU; 
Sigma-Aldrich, Inc., St. Louis, MO; 100 mg/kg i.p.) in sterile saline, and anesthetized and 
perfused with 3% paraformaldehyde two hours later, followed by tissue harvesting (brain, nasal 
cavity including olfactory epithelial tissue, eyes, liver and gut), processing and sectioning 
(coronal) as previously described (Kwong et al. 2004).  For RNA expression analysis, following 
euthanasia with CO2, the olfactory epithelium (OE) from the remaining four Hq/Y mice and 
three +/Y mice were quickly removed, weighed, and snap-frozen in liquid nitrogen. 
 
Cellular localization of olfactory marker protein (OMP), AIF and 8OHdG 
 Standard indirect immunofluorescence techniques were used as previously described 
(Nan et al. 2001) to visualize the mature olfactory sensory neuronal (mOSN) marker OMP; AIF; 
and the DNA damage marker 8OHdG.   The goat polyclonal antibody for OMP, a generous gift 
of Dr. F. L. Margolis, University of Maryland, Baltimore, MD, was used at a dilution of 1:1,000; 
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immunoreactivity was visualized with FITC-conjugated donkey anti-goat IgG (Jackson 
ImmunoResearch, West Grove, PA) at a dilution of 1:100.  To localize AIF protein, a mouse 
monoclonal antibody (E-1, Santa Cruz Biotechnology, Santa Cruz, CA) was used at 1:50 
dilution; for 8OHdG, a mouse monoclonal antibody (QED Bioscience Inc, San Diego, CA) was 
used at a dilution of 1:500.  For both, immunoreactivity was visualized using FITC- or 
Rhodamine Red-X (RRX)- conjugated donkey anti-mouse IgG.  For co-localization experiments, 
AIF or 8OHdG and OMP antibodies were applied to the sections simultaneously and incubated 
overnight.  The sections were washed with PBS, incubated with FITC-conjugated donkey anti-
mouse IgG (1:100) for AIF or 8OHdG, washed again, and incubated in RRX-conjugated donkey 
anti-goat IgG (1:150) for OMP.  Sections stained for AIF, 8OHdG and OMP were examined and 
photographed with a Leica TCS SP upright confocal microscope with a DM RXE precision 
focusing nosepiece (Leica Microsystems GmbH, Wetzlar, Germany) with argon (green) and 
krypton (red) lasers.  To evaluate the amount of autofluorescent lipofuscin, a marker of 
(primarily) undegraded oxidized protein, sections were rehydrated in PBS, cover slipped, and 
examined through the FITC filter of a Leitz Aristoplan microscope with a xenon light source.  
Images were processed with Adobe Photoshop C52 (Adobe Systems, Inc., San Jose, CA). 
 
Cellular localization of apoptotic cells, apoptotic bodies, and macrophages 
 Peroxidase immunohistochemistry for the apoptotic cell marker cleaved caspase-3 was 
performed using the Vectastain Elite ABC Kit according to manufacturer’s directions (Vector 
Laboratories, Burlingame, CA).  Polyclonal antibody against cleaved caspase-3 (Cell Signaling 
Technology, Beverly, MA) was used at a 1:50 dilution.  Briefly, endogenous peroxidase activity 
was quenched with 7.5% H2O2 in 100% methanol for 30 min.  Sections were incubated in diluted 
normal blocking serum for 20 min, in the primary antibody for 30 min, in the biotinylated 
secondary antibody for 30 min, in the Vectastain Elite ABC reagent 30 min, and finally in the 
peroxidase substrate aminoethyl carbazole (AEC; Zymed/Invitrogen, Carlsbad, CA).  Sections of 
spleen, where numerous apoptotic cells occurred, were stained as positive controls.  For 
quantification, cleaved caspase-3 immunoreactive cells were counted in five 250-μm lengths of 
OE each on both sides of the septum and on turbinate IIa on one side of the nasal cavity (n = 15 
fields).  This procedure was performed in three sections per mouse, two mice per strain (Hq/Y 
and +/Y).  Sections approximately 100 µm apart from the same region of the nasal cavity were 
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used for all mice.  The number of apoptotic cells in each section was averaged for each mouse, 
and box plots that represent the means falling within the 25th to 75th percentiles were generated 
from the 6 resultant means from each strain using Sigma Plot (Systat Software, Inc., Richmond, 
CA).  The medians of the means for each strain were indicated by the horizontal lines in each 
box. 
 To visualize apoptotic bodies, nuclei were stained with bisbenzimide (Hoechst 33258; 
Sigma-Aldrich).  Sections were incubated in a solution of 1:105 bisbenzimide in PBS for three 
min at room temperature, rinsed in PBS, coverslipped and visualized with the Aristoplan 
microscope and a broad-band fluorescence filter.  To identify macrophages, a mouse monoclonal 
antibody for the pan-macrophage marker CD68 (Serotec, Raleigh, NC) was used at a 1:50 
dilution and an RRX-conjugated donkey anti-rat IgG (Jackson ImmunoResearch) at a dilution of 
1:200. 
 
Characterization of cellular architectural changes 
 Hematoxylin and eosin staining was used to compare the basic cellular architecture of the 
OE, olfactory bulb (OB), cerebellum, and retina of Hq/Y and +/Y mice.  To investigate the 
appearance of the OE basement membrane, a rabbit polyclonal antibody to α-laminin (1:500 
dilution; Sigma-Aldrich) was used, followed by an FITC-conjugated donkey anti-rabbit IgG 
(Jackson ImmunoResearch). 
Controls in which the primary antibody was omitted from the staining protocol were performed 
for all immunohistochemical experiments.  In all cases, no staining was observed in the OE. 
 
RNA isolation 
 Frozen tissue was pulverized in TRI Reagent (Sigma-Aldrich, St. Louis, MO) and 
processed through a QIAshredder column (Qiagen, Valencia, CA).  The total RNA was further 
purified using the Qiagen RNeasy Mini-Kit according to the manufacturer’s protocol.  Total 
RNA yield and purity was assessed with a spectrophotometer and with the model 2100 
Bioanalyzer (Agilent Technologies, Palo Alto, CA); all samples had A260/A280 ratios of 1.9–
2.2 and showed two sharp peaks corresponding to 18S and 28S RNA on the Bioanalyzer 
electropherograms. 
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High density oligonucleotide arrays 
 Affymetrix Murine Genome 430 2.0 microarrays (Affymetrix, Santa Clara, CA) were 
processed at the University of Kentucky Microarray Core Facility.  A total of six GeneChips 
(three for Hq/Y mutant and three for +/Y control mice) were used.  Following target preparation, 
hybridization, and signal acquisition according to standard Affymetrix protocols, the normalized 
hybridization signals were analyzed with the Affymetrix Microarray Suite 5.0; a threshold value 
of 1,500 was used to normalize the data across all the microarrays.  The hybridization signal for 
each probe set was assigned an “absolute call” of “Present,” “Marginal,” or “Absent.”  To be 
included in the subsequent statistical analyses, a probe set was required to be identified as 
Present on at least one of the six microarrays and the identity of the gene associated with the 
probe set known.  The microarray data set was deposited into the Gene Expression Omnibus 
(GEO) database; the series accession number is GSE6485. 
 
Statistical Analysis 
 The mean hybridization signals for all of the Present known genes were analyzed with 
two-tailed Student’s t-tests for each gene.  Genes that were differentially expressed at two levels 
of significance, p < 0.05 and p < 0.01, were used in subsequent analyses; genes that had p-values 
of < 0.05 were used only in the bioinformatics analysis (see below).  A histogram of the relative 
frequencies of p-values of the 20,664 Present known genes was plotted to assess their 
distribution; for comparison, a similar histogram was generated for 12,164 Present known genes 
from another data set in which olfactory bulbectomy (OBX) was performed as previously 
reported (Getchell et al. 2005), and differential gene expression in the olfactory epithelium was 
compared in sham-bulbectomized and bulbectomized mice. 
 A probit transformation was applied to the p-values of all Present known genes.  If the p-
values were from a uniform (0,1) distribution, the probit-transformed p-values would follow a 
standard normal distribution; if the p-values were not from a uniform distribution, the probit-
transformed p-values would deviate from the normal distribution.  A quantile-quantile (q-q) plot 
was generated to assess the normality of the transformed p-values.  A one-sided one sample 
Kolmogorov-Smirnov (KS) test was also performed to determine if the p-values of the 221 genes 
with p < 0.01 were significantly smaller than would be expected by chance. 
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 Data management was performed with Excel (Microsoft, Redmond, WA), and statistical 
and graphic analysis was performed with SAS (SAS Institute, Cary, NC), R software 
(http://cran.us.r-project.org/), and SigmaPlot (SPSS, Chicago, IL). 
 
Bioinformatics analysis 
 Expression Analysis Systematic Explorer (EASE) software (Hosack et al. 2003) was used 
to identify significantly over-represented categories in the up- and down-regulated genes with p 
< 0.05 among the Present known genes.  The descriptors used were the Cellular Component, 
Biological Process, and Molecular Function categories as defined by Gene Ontology (GO; 
http://www.geneontology.org/). 
 
Real time RT-PCR 
 Real-time PCR was performed on aliquots of cDNA reverse-transcribed from the same 
total RNA that was used for microarray hybridization.  The reactions were performed using 
cDNA equivalent to 10 ng of RNA, 300 nM each of forward and reverse primers, and 
QuantiTect SYBR Green PCR Master Mix (Qiagen) according to the manufacturer’s protocol in 
the ABI Prism 7000 Sequence Detection System (Applied Biosystems, Foster City, CA).  
Primers for each gene spanned at least one intron, except those for OMP, an intronless gene.  
Primer sequences, annealing temperature, amplicon size and melting temperature, and the 
citations for the sources of the primers are listed in Table 4.1 (Atsawasuwan et al. 2005; Douglas 
and Camper 2000; Li et al. 2006; Siu and Alway 2005).  Reaction parameters were as follows: 2 
min at 50°C; 15 min at 95°C; 40 cycles of 15 s each at 94°C, 30 s at the appropriate annealing 
temperature, and 1 min at 72°C.  Control and experimental cDNA, cDNA for the derivation of 
standard curves, and no-template controls were run in triplicate.  A dissociation curve was 
obtained at the end of each reaction to verify the presence of a single product with the 
appropriate melting point for each product.  The presence of a single product from each reaction 
and its size were also confirmed on a 2% agarose gel stained with ethidium bromide.  Real time 
RT-PCR for OMP mRNA was performed as previously described (Kwong et al. 2004) to 
confirm that the total RNA was extracted from OE, and in every case, this was confirmed.  The 
comparative threshold cycle (CT) method was used to analyze relative changes in gene 
expression.  The average CT values for each triplicate from each of the three Hq/Y or three +/Y 
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mice were evaluated with an unpaired t-test.  Relative quantification and fold changes were 
calculated using the standard curve method as previously described (Kwong et al. 2004). 
 
Note on terminology 
 Although the name of the Pdcd8 gene was changed to Aifm1 (apoptosis-inducing factor, 
mitochondrion-associated 1) in the NCBI Entrez Gene database in November, 2006, we have 
used the previous designation to remain consistent with the terminology used for the Affymetrix 
GeneChips and in the current literature. 
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Table 4.1.  Real-time RT-PCR primers 
 
Target  Primer Sequence Primer
Ta 
Amplicon 
Size 
Amplicon 
Tm 
Reference 
Pdcd8 
 
F:5’CCGGCTTCCAGGCAACTTGTTCC 
R:5’CCCGGATGGATCTGGCTGCTGCA 
60 °C 359 bp 
 
83 °C (62) 
Cct4 F:5’ TGATTGACCCAGCCACAGCTA 
R:5’ TCTGTGTGAGAACGAGGCCTTC 
55 °C 114 bp 78 °C PE* 
Cxcl12 
 
F:5’CGTGAGGCCAGGGAAGAGT 
R:5’TGATGAGCATGGTGGGTTGA 
45 °C 68 bp 80 °C (44) 
Amph 
 
F:5’ACGAGGGGGCAAAAGAAC 
R:5’CAGCATACATCACCTCGTTCA 
45 °C 109 bp 74 °C (16) 
Loxl2 
 
F:5’GCCCTCCGATGTGGTCAAG 
R:5’GCCCTCCTTCACCTCCACGTAG 
50 °C 486 bp 87 °C (4) 
Parp2 
 
F:5’ TCTGTAACGTGCAGACCATGGA 
R:5’ TGAGAGACTGGTAACCGGCCTT 
55 °C 114 bp 80 °C PE* 
* PE, Primer Express software, Applied Biosystems;  
Ta, primer annealing temperature; Tm, amplicon melting temperature. 
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Results 
 
Cellular localization of AIF in the OE 
 AIF is the protein product of Pdcd8, which carries the Harlequin mutation in the Hq/Y 
mice.  To demonstrate AIF expression in the OE and qualitatively assess differences in 
expression and localization between the mutant Hq/Y and control +/Y mice, we performed 
immunofluorescence staining with an antibody to AIF (Figure 4.1).  We observed AIF 
immunoreactivity in all layers of the OE in the +/Y controls.  The staining appeared punctate and 
was localized primarily in the perinuclear region and dendrites of mOSNs (Figure 4.1A), which 
coincides with the reported primary sites of localization of mitochondria in OSNs (Naguro and 
Iwashita 1992).  In contrast, in the Hq/Y mutant mice, immunoreactivity for AIF was negligible 
in most regions of the OE (Figure 4.1B).  However, on some turbinates, clusters of strongly 
immunoreactive cells were observed (Figure 4.1C).  These cells exhibited a very different pattern 
of immunoreactivity than those in the +/Y mice in that the staining was more diffuse and less 
punctate, apparently cytosolic, suggesting the possible translocation of AIF out of the 
mitochondria, and was more concentrated in the supranuclear region of the OSNs.  These results 
demonstrated that AIF was abundant and most likely mitochondrial in the +/Y controls, whereas 
although it was seldom observed in the Hq/Y mutant OE, it was most likely cytosolic in the cells 
in which it occurred. 
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Figure 4.1.  Immunofluorescence staining for apoptosis-inducing factor (AIF) in the olfactory 
epithelium (OE).  Representative confocal images are shown for a 6-month old Harlequin mutant 
mouse (Hq/Y) and its littermate control (+/Y).  AIF-immunoreactive cells were seen in the OEs 
of both Hq/Y mutants and +/Y controls.  Punctate staining was observed throughout the OE of 
+/Y controls (A), primarily the perinuclear region and at the surface in what appeared to be 
dendrites (arrows) of the mature olfactory sensory neurons (mOSNs).  In the Hq/Y mutant mice, 
AIF was undetectable in majority of the OE (B), with the exception of infrequent clusters of 
immunoreactive cells resembling mOSNs on certain turbinates (C, arrows) which exhibited 
intense cytosolic staining.  Calibration bars:  20 μm 
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Oxidative damage in the Harlequin mutant mouse OE 
 The decreased abundance of AIF in Hq/Y mutant mice was reported to increase their 
susceptibility to oxidative stress-associated DNA damage and apoptosis in the retina and 
cerebellum (Klein et al. 2002).  To assess whether there was an increase in oxidative DNA 
damage in the OE of Hq/Y mutant mice, I performed immunofluorescence staining for 8OHdG, 
a marker of oxidative DNA damage, in sections near-adjacent to those in which AIF was 
localized (Figure 4.2).  While 8OHdG was undetectable in the OE of +/Y controls (Figure 4.2A), 
we observed numerous strongly immunoreactive cells in the OE of Hq/Y mutant mice (Figure 
4.2B).  The 8OHdG immunoreactivity in the Hq/Y mutants was primarily extranuclear, 
suggesting increased mitochondrial oxidative DNA damage.  Large numbers of 8OHdG positive 
cells were observed in the OE on both on the septum and turbinates.  The shape and location of 
most of the immunoreactive cells suggested that they were likely to be OSNs.  The 
autofluorescent pigment lipofuscin, which indicates the cellular accumulation of oxidized 
macromolecules, primarily proteins, also differed in abundance and localization in the Hq/Y 
mutant and +/Y control mice.  In the +/Y control mice, a small amount of lipofuscin was 
confined to a region near the OE basement membrane (Figure 4.3A); in contrast, in the Hq/Y 
mouse, a large amount of lipofuscin, distributed throughout the OE, was concentrated in the 
lower quarter of the epithelium (Figure 4.3C).   Taken together, these results demonstrate that 
there is elevated DNA and protein oxidative damage in the OE of the Hq/Y mutant mouse 
compared to the +/Y controls. 
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Figure 4.2.  8-Hydroxydeoxyguanosine (8OHdG) immunofluorescence in the olfactory 
epithelium (OE).  Representative confocal images of OE sections adjacent to those stained for 
AIF and stained with an antibody to 8OHdG are shown (A, B).  In the +/Y controls (A), 
negligible immunoreactivity for 8OHdG was observed.  In contrast, in the Hq/Y mutant mice, 
numerous cells resembling mature olfactory sensory neurons (mOSNs) were strongly 
immunoreactive for 8OHdG (B, arrows).  A photomicrograph of the Hq/Y mutant OE taken with 
a standard fluorescence microscope showing a representative no-primary control (C) shows 
negligible staining.  Calibration bars:  A and B, 20 μm; C, 25 μm. 
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Figure 4.3.  Increased lipofuscin and macrophage infiltration in the olfactory epithelium (OE) of 
Harlequin mutant mice.  Faint autofluorescent lipofuscin was observed in the basal cell layer of 
the OE of 6-month old +/Y control mice, apparently in the foot processes of sustentacular cells 
(A).  In contrast, intense lipofuscin autofluorescence was present, apparently in the foot 
processes of the sustentacular cells, as well as throughout the epithelium in the Hq/Y mutant 
mice (C).  A few CD68-positive macrophages (e.g., arrow, B) were present in the OE and lamina 
propria of +/Y control mice; a pronounced increase in the number of CD68-positive 
macrophages (e.g., arrows, D) was observed in both the epithelium and the lamina propria in 
Hq/Y mutant mice.  Calibration bar, 25 μm. 
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Localization of AIF and 8OHdG in mOSNs 
 Both AIF and 8OHdG were localized in the OE, primarily in cells that resembled OSNs.  
To determine whether AIF and 8OHdG were localized in mOSNs, I performed double 
immunofluorescence staining with antibodies for each of these proteins and for OMP (Figure 
4.4).  We observed striking differences in the localization of AIF between the +/Y controls and 
the Hq/Y mutant mice.  In the +/Y controls, the widespread punctate immunoreactivity for AIF 
(Figure 4.4A), when merged with the immunoreactivity for OMP (Figure 4.4B), largely co-
localized with OMP (Figure 4.4C, yellow), both in the perinuclear cytosol and dendrites of 
mOSNs.  Although AIF-immunoreactive cells were seldom observed in most of the OE of Hq/Y 
mutant mice, the occasional strongly AIF-immunoreactive cells (Figure 4.4D), when merged 
with OMP immunoreactivity (Figure 4.4E), were usually also OMP-positive (Figure 4.4F, 
yellow), confirming the localization of AIF in mOSNs.  Unlike the +/Y controls, no punctate 
mOSN dendritic immunoreactivity was detected in the Hq/Y mutants.   These novel results 
demonstrated that AIF was expressed by mOSNs both in the +/Y control and the Hq/Y mutant 
mice but that the numbers of AIF-immunoreactive neurons and the pattern of intracellular 
localization differed between the mutants and controls.  
 Immunoreactivity for the DNA damage marker 8OHdG was negligible in the +/Y control 
mice (Figure 4.4G), and when merged with OMP immunoreactivity (Figure 4.4E), negligible co-
localization was observed (Figure 4.4I).  In contrast, numerous cells strongly immunoreactive for 
8OHdG (Figure 4.4J) occurred in the Hq/Y OE, the majority of which were also immunoreactive 
for OMP (Figure 4.4K, L).  The co-localization of 8OHdG and OMP observed in the Hq/Y OE 
was primarily in the supranuclear region, and punctate 8OHdG also co-localized with OMP in 
some mOSN dendrites, consistent with the reported location of mitochondria in mOSNs.  These 
results demonstrated that oxidative DNA damage, which was negligible in the +/Y controls, was 
highly elevated in the mOSNs of the Hq/Y mutant mice. 
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Figure 4.4.  Co-localization of apoptosis-inducing factor (AIF) and 8-hydroxydeoxyguanosine 
(8OHdG) with olfactory marker protein (OMP) in the olfactory epithelium (OE).  AIF (A-F).  
AIF immunoreactivity is localized in the perinuclear region and dendrites (green, A) of cells that 
resemble mature olfactory sensory neurons (stained for OMP, red, B) in +/Y controls.  Co-
localization of AIF and OMP is confirmed in (C), in which mOSNs appear yellow (C) in the 
merged images.  In Hq/Y mutants, infrequent clusters of AIF-positive cells (green, D) resemble 
mOSNs (red, E).  Co-localization is demonstrated in the merged image (yellow, F).  8OHdG (G-
L).  There was negligible 8OHdG immunoreactivity in the OE of +/Y control mice (G), although 
OMP-positive mOSNs (red, H) were abundant.  There was negligible evidence of co-localization 
(I, yellow).  In the Hq/Y mutant mouse, numerous 8OHdG-positive cells were observed 
throughout the OE (green, J) that resembled mOSNs (red, K).  Co-localization (yellow, L) 
confirmed that most of the cells showing oxidative DNA damage were mOSNs.  Calibration bar, 
20 μm. 
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Apoptosis in the OE of Harlequin mutant mice 
 Increased oxidative DNA and protein damage predisposes neurons to apoptotic cell 
death.  To determine whether there was an increase in apoptotic cell death concomitant with the 
increased oxidative DNA damage in the OE of the Hq/Y mutant mice, I performed 
immunohistochemistry for the cleaved (active) form of the apoptosis effector caspase-3 (Figure 
4.5).  In a typical section of OE from the +/Y control mice, we observed no caspase-3 
immunoreactive cells (Figure 4.5A).  In contrast, numerous cleaved caspase-3 positive cells were 
present throughout the OE of the Hq/Y mutant mice (Figure 4.5C).  Quantification of the 
apoptotic cells is presented by box plots (Figure 4.5E), in which the boxes show the spread of the 
means of the number of cleaved caspase-3-positive cells between the 25th and 75th percentiles in 
the two strains of mice.  The median of the mean numbers of apoptotic cells, as shown by the 
horizontal line in each box, was higher in the OE of Hq/Y mutants than in +/Y controls.  The 
mean number of cleaved caspase-3 positive cells was 3.4-fold higher in the OE of Hq/Y mutant 
mice compared to +/Y controls, demonstrating an increase in apoptosis.  Apoptotic bodies, 
demonstrated by bisbenzimide staining of near-adjacent OE sections from +/Y control and Hq/Y 
mutant mice (Figure 4.5B, D, and F respectively) were more abundant in the Hq/Y mutant mice 
than in +/Y controls, confirming our results with cleaved caspase-3.  Also consistent with these 
results, there was a 1.6-fold greater number of CD68-positive macrophages, which are 
scavengers of apoptotic cells in the OE (Getchell et al. 2006; Suzuki et al. 1995), in the OE of 
Hq/Y mutants compared to +/Y controls (Figure 4.3 B, D). 
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Figure 4.5.  Cellular analysis of apoptosis in the Harlequin mouse olfactory epithelium (OE).  
Cleaved caspase-3 immunoreactivity (A, C, E).  Typically, no cells immunoreactive for cleaved 
caspase-3 were observed in the OE of +/Y control mice (A).  In the Hq/Y mutant mice (C), 
cleaved caspase-3-immunoreactive cells (black arrows) occurred throughout the OE.  A 
comparison of the mean numbers of apoptotic cells in the two strains is represented in the box 
plots (E), where each box represents the values of the means of the numbers of apoptotic cells 
that fell within the 25th to 75th percentiles (see text for details).  The horizontal line in each box 
indicates the median of the mean numbers of apoptotic cells in the +/Y controls (left) and Hq/Y 
mutants (right), confirming that there were more apoptotic cells in the OE of the mutants than 
controls.  Bisbenzimide staining (B, D, F).  Sections near those stained for cleaved caspase-3 
immunoreactivity were stained with bisbenzimide to visualize apoptotic bodies, which were 
more abundant in the OE of the Hq/Y mutants (D, white arrows, and enlarged inset, F) compared 
to +/Y controls (B, white arrow).  Calibration bars:  25 μm. 
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Other cellular changes in the OE of Hq/Y mice 
 To assess the general cellular organization of the olfactory mucosa in the Hq/Y mutants 
compared to the +/Y controls, sections were stained with hematoxylin and eosin (Figure 4.6A, 
C).  The major differences were the apparent presence of discontinuities in the OE basement 
membrane with a resultant lack of a clear delimitation of the OE from the lamina propria, and an 
apparent disaggregation of the olfactory nerve bundles (ONBs) in the lamina propria.  To assess 
the integrity of basement membranes in the olfactory mucosae of Hq/Y and +/Y mice, 
immunoreactivity for α-laminin was compared.  The OE basement membrane (arrowheads) was 
relatively distinct in the +/Y control (Figure 4.6B), but appeared diffuse and highly 
discontinuous in the Hq/Y mutant (Figure 4.6D).  Additionally, the large ONBs with thick α-
laminin-containing basement membranes evident in the +/Y controls are replaced by smaller, 
less distinct ONBs in the Hq/Y mutants. 
 
Oxidative changes in the olfactory bulbs (OBs) of Hq/Y mutant mice 
 Because of the increased incidence of oxidative stress that we demonstrated in the 
mOSNs of Hq/Y mutant mice, we investigated the second-order targets of the mOSNs, the mitral 
cell neurons, in the OBs of the mutant and control mice.  Cresyl violet staining to demonstrate 
the general organization of the mitral cell layer (Figure 4.7) suggested a somewhat decreased 
cellularity in the Hq/Y mutants (Figure 4.7D) compared to the +/Y controls (Figure 4.7A).  In 
contrast to the lack of changes in the OB reported by Klein et al. (Klein et al. 2002), we observed 
a clear increase in oxidative DNA damage, as indicated by 8OHdG staining, in the mitral cells of 
the Hq/Y mutants (Figure 4.7E) compared to that in the +/Y controls (Figure 4.7B).  Similarly, 
lipofuscin, indicative of the accumulation of primarily oxidized protein, was more abundant in 
the mitral cell layer of the Hq/Y mutants (Figure 4.7F) compared to the +/Y controls (Figure 
4.7C).  We observed no cleaved caspase-3 staining in the OBs of either the Hq/Y mutant or +/Y 
control mice (not shown). 
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Figure 4.6.  Laminar disorganization in the olfactory epithelium (OE) of Harlequin mutant mice.  
Hematoxylin and eosin (H&E, A, C) staining and α-laminin immunofluorescence (B, D) are 
shown for +/Y controls and Hq/Y mutant mice. H&E shows the disaggregation of olfactory 
nerve bundles (e.g., asterisk) in the Hq/Y mutant mouse OE (C) compared to +/Y controls (A).  
The discontinuous nature of the basement membrane (arrowheads) is indicated in the Hq/Y 
mutant compared to control mouse OE by H&E staining (A, C) and confirmed by α-laminin 
immunofluorescence (B, D).  Calibration bar, 25 μm. 
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Figure 4.7.  Oxidative damage in the mitral/tufted cell layer (MCL) in olfactory bulbs (OBs) of 
Harlequin mutant mice.  Cresyl violet staining (A, D), 8-hydroxydeoxyguanosine (8OHdG, B, E) 
immunofluorescence, and autofluorescent lipofuscin (C, F) in sections of OB from +/Y control 
(upper panel) and Hq/Y mutant (lower panel) mice are shown.  Immunoreactivity for 8OHdG (B, 
E) was localized in mitral/tufted cells, shown by cresyl violet staining (A, C) of near-adjacent 
sections.  Sparse cytoplasmic 8OHdG immunoreactivity is localized in mitral/tufted cells in +/Y 
control mice (B, arrows).  More intense cytoplasmic 8OHdG immunoreactivity occurs in 
mitral/tufted cells in Hq/Y mutant mice (E, arrows).  Lipofuscin (gold), an autofluorescent 
marker of primarily oxidized protein , , was more abundant and intense in the MCL of Hq/Y 
mutant mice (F, arrows) compared to the +/Y controls (C, arrows). EPL, external plexiform 
layer; IPL, internal plexiform layer; GCL, granule cell layer.  Calibration bar, 25 μm. 
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Confirmation of cellular changes in the cerebellum and retina of the Hq/Y mutant mice 
 To confirm that the Hq/Y mutants from which we obtained olfactory tissues showed the 
hallmark changes in the cerebellum and retina that were characterized by Klein et al. (Klein et al. 
2002), I stained these tissues with cresyl violet and compared them to the +/Y controls.  In the 
cerebellum, (Figure 4.8A, B), there is an apparent decrease in the cellularity of the proximal 
molecular, Purkinje, and granule cell layers and an increase in vacuolation in the Purkinje cell 
layer in the Hq/Y mutants compared to the +/Y controls.  In the retina, the overall thickness was 
substantially reduced and was accompanied by an apparent reduction in the thickness of all 
layers.  We also observed an increase in the number of cleaved caspase-3 immunoreactive cells 
in the retinas of Hq/Y mice (not shown). 
 In summary, these novel cellular results have demonstrated the expression of AIF in 
mOSNs in +/Y control mice and a substantial decrease in its abundance in the Hq/Y mutants.  In 
addition, I have demonstrated a substantial increase in markers of oxidative stress in mOSNs and 
other cells in the OE as well as an increased number of apoptotic cells in the OE of the Hq/Y 
mutant mice compared to +/Y controls.  These cellular results provided a framework for our 
microarray and bioinformatics analyses, which begin to elucidate the mechanisms underlying 
oxidative stress-associated changes in the OE of the Harlequin mice. 
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Figure 4.8.  Degenerative changes in the cerebellum and retina of Harlequin mice.  Cresyl violet 
staining of sections of cerebellum (upper panel) and retina (lower panel) for 6-month old +/Y 
control (A, C) and Hq/Y mutant (B, D) mice is shown.  Distinct cellular layers were observed in 
the cerebellum of +/Y control mice (A), namely the molecular layer (ML), purkinje cell layer 
(PCL) and granule cell layer (GrCL).  Unlike the +/Y control, all cellular layers of the Hq/Y 
mouse cerebellum were less dense, particularly the GrCL (B). In addition, prominent vacuolation 
was observed in the ML and PCL (B).  The retina of the 6-month old +/Y control mice clearly 
showed all layers, namely the ganglion cell layer (GCL), inner plexiform layer (IPL), inner 
nuclear layer (INL), outer plexiform layer (OPL), outer nuclear layer (ONL) and retinal pigment 
epithelium (R).  In the Hq/Y mutant mice, a decrease in cellularity was observed in all layers, 
and a concomitant decrease in overall retinal thickness was observed.  Calibration bar, 25 μm.
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Microarray analysis and identification of regulated genes in the OE of Hq/Y mice 
 The flowchart (Figure 4.9) outlines the data scrubbing and statistical analysis of 
GeneChip data obtained from three Hq/Y mutant and three +/Y control mouse OEs to identify 
significantly regulated genes.  We began by removing the 64 quality control probe sets and 
17,635 probe sets representing expressed sequence tags (ESTs) and other non-annotated genes 
from the 45,101 probe sets on the MG 430 2.0 whole mouse genome GeneChip.  An absolute 
call analysis on the remaining 27,402 probe sets resulted in the identification of 20,664 known 
genes that were Present on at least one of the six GeneChips; of these, 1,019 had p-values < 0.05, 
with 488 up-regulated and 531 down-regulated.  For subsequent analyses (with the exception of 
the bioinformatics analysis), the level of significance was set at p < 0.01 to reduce the number of 
potential false positives; 221 genes had p-values < 0.01, with 107 up-regulated and 114 down-
regulated.  Most importantly, the microarray data indicated that the Pdcd8 gene, which encodes 
AIF protein, was significantly down-regulated by 4.8-fold in the OE of Hq/Y compared to +/Y 
mice (p = 7.3E-05; Figure 4.10). 
 In order to visualize the distribution of p values resulting from the Hq/Y vs. +/Y 
comparison, a histogram of the relative frequencies of the p-values of the 20,664 Present known 
genes was generated.  The histogram (Figure 4.11A) showed a very different distribution of p-
values for the Hq/Y vs. +/Y data set than those obtained from previous data from several of our 
experiments in which a manipulation such as olfactory bulbectomy (OBX) was performed (e.g., 
Figure 4.11B).  OBX results in anterograde OSN degeneration, an innate immune response, and 
epithelial remodeling, which are responses that induce the coordinated, short-term regulation of 
many genes (Getchell et al. 2006; Getchell et al. 2005); this is reflected in the skewing of the 
histogram toward low p-values (Figure 4.11B).  In contrast, the single gene mutation in the Hq/Y 
mice that resulted in an 80% reduction in Pdcd8 expression resulted in the significant regulation 
of a relatively small number of genes (Figure 4.11A). 
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Figure 4.9.  Flowchart summarizing experimental design and results of microarray analysis to 
identify significantly regulated genes in the Hq/Y mutant mice compared to +/Y controls. Probe 
sets/genes included and statistical test used in the analysis are indicated in bold. 
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Figure 4.10.  Regulation of Pdcd8 gene expression.  Microarray analysis demonstrated that there 
was a highly significant (p = 7.3E-05) 4.8-fold down-regulation of the mean hybridization 
signals of the Pdcd8 gene in the Hq/Y mutants compared to +/Y controls.  ***, p < 0.001; SEM, 
standard error of the mean; n = 3 per group. 
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Figure 4.11.  Histograms of relative frequencies of p-values.   
A.  Histogram of relative frequencies of p-values of Present known genes in the olfactory 
epithelium (OE) from the Hq/Y vs. +/Y microarray analysis. The bin for genes with p < 0.01 is 
indicated by a white arrowhead.  B.  Histogram of relative frequencies of p-values of Present 
known genes in the OE from an experiment in which olfactory bulbectomy was performed (see 
text for details).  Note the difference in the pattern of distribution of p-values in A and B. 
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 In order to more closely examine the distribution of genes with low p-values, a probit 
transformation was performed on the p-values for the 20,664 Present known genes, and a normal 
probability or quantile-quantile (q-q) plot of the observed vs. theoretical transformed p-values 
(Figure 4.12A) was generated.  This analysis clearly showed that the genes with the lowest 
transformed p-values deviated from a normal distribution (diagonal straight line), as seen in the 
inset showing the quantiles of the probit-transformed p-values for the 221 genes with p < 0.01.  
Additionally, a one-sided one sample KS test indicated that the 221 genes had significantly (p < 
0.05) smaller p-values than would be expected if they were from a uniform distribution. 
 Another way of representing the distribution of p-values is a volcano plot (Figure 4.12B), 
which illustrates the relationship between the p-value (represented on the y-axis as –log10) and 
fold change in expression (represented on the x-axis as log2) for each of the 20,664 Present 
known genes.  The p-values for genes that fell above the gray dashed horizontal line were less 
than 0.05, and for those above the black dashed horizontal line were less than 0.01.  Most of the 
221 significantly regulated genes (p < 0.01, open black circles) were up- or down-regulated less 
than 2-fold (quadrant 2).  Genes up-regulated 2-fold or more are shown in quadrant 1, and genes 
down-regulated 2-fold or more are shown in quadrant 3 (listed in Table 4.2).  More genes were 
down-regulated greater than 2-fold than were up-regulated greater than 2-fold.  Two genes, Klc2 
and Cd99l2, had p-values lower than that of Pdcd8.  Klc2 (kinesin light chain 2, p = 9.2E-06, 
quadrant 1), whose protein product is involved in the tethering of axonal vesicles to microtubules 
for intraneuronal transport (Frederikse et al. 2004), was up-regulated 2.2-fold.  Cd99l2 (CD99 
antigen-like 2, p = 1.9E-05, quadrant 3), which is highly expressed in neurons (Suh et al. 2003), 
was down-regulated 4.8-fold. 
 To understand the functional significance of the changes in gene expression in the Hq/Y 
mutant mice, we performed bioinformatics analysis on the significantly regulated genes in two 
ways, both of which relied on functional categories assigned by GO.  First, we performed a 
broad classification of the significantly regulated genes (p < 0.01) based on a combination of GO 
functional category descriptors and literature searches.  Second, we used EASE to identify 
significantly over-represented categories among the up-regulated and down-regulated genes 
based GO categorical systems.  The first approach, the results of which are illustrated as a pie 
chart (Figure 4.13) and listed in Table 4.2 and 4.3, demonstrated that the majority of these genes 
belonged to the neurodegeneration-associated categories of apoptosis/cell cycle, oxidative stress, 
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and extracellular matrix/transport.  A subset of these genes, which were up- or down-regulated 2-
fold or more are listed (Table 4.4), under their primary functional category.  The second 
approach was to use EASE analysis (Table 4.5), which is based on the number of significantly 
regulated genes (p < 0.05) in a particular category compared with the remaining Present known 
genes.  The EASE results demonstrated that significantly up-regulated genes were associated 
with the mitochondrion, nucleus and endoplasmic reticulum, cellular sites that are particularly 
involved in oxidative stress responses.  The majority of the genes in the co-enzyme prosthetic 
group metabolism/porphyrin Biological Process group are electron transport-associated, 
emphasizing the involvement of AIF in mitochondrial function and oxidative stress.  
Significantly down-regulated genes indicate cytoskeletal breakdown and decreased neurogenesis 
as well as transcriptional repression. 
 Genes for validation with real time RT-PCR were selected based on the p-value/fold 
change relationship as shown in the volcano plot (Figure 4.12B, red and blue circles) and on their 
relationship to relevant categories as indicated by the bioinformatics analyses (Figure 4.13, Table 
4.2). 
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Figure 4.12.  Graphical analyses of microarray data.  
A.   The normal probability or quantile-quantile (q-q) plot of the probit-transformed p-values for 
all Present known genes.  The graph demonstrates that although the majority of the transformed 
p-values followed a normal distribution (diagonal straight line); the lowest transformed p-values 
deviated from the line.  The inset illustrates the deviation of the transformed p-values of the 221 
genes with p < 0.01 from the normal distribution. B.  Volcano plot of Present known genes 
shows the relationship between p-values (expressed as –log10) and fold changes (expressed as 
log2).  The dashed gray horizontal line is p = 0.05; the dashed black horizontal line is p = 0.01.  
The 2 dashed vertical lines equal 2 fold down-regulated expression (left) and up-regulated 
expression (right).  The genes in quadrant 1 have p < 0.01 and are up-regulated 2-fold or more, 
the genes in quadrant 2 have p < 0.01 and are up- or down-regulated less than 2 fold, and the 
genes in quadrant 3 have p < 0.01 and are down-regulated 2 fold or more.  Genes selected for 
validation with real time RT-PCR are shown in red (down-regulated) and blue (up-regulated). 
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Table 4.2. Genes down-regulated with p < 0.01 
 
Probeset ID p-value FC Gene symbol 
Apoptosis/Cell cycle   
1418127_a_at 7.29E-05 4.72 Pdcd8* 
1452911_at 2.47E-04 1.41 Spred1 
1418880_at 3.24E-04 1.52 Gfra3 
1427940_s_at 3.35E-04 1.21 Mycbp 
1447913_x_at 3.54E-04 1.65 Akap9 
1456375_x_at 9.86E-04 1.19 Trim27 
1456482_at 1.40E-03 1.04 Pik3r3 
1420579_s_at 1.75E-03 1.23 Cftr 
1432614_at 1.89E-03 1.37 Wdr37 
1448986_x_at 2.24E-03 1.56 Dnase2a 
1425492_at 2.35E-03 1.14 Bmpr1a 
1455717_s_at 2.96E-03 1.31 Daam2 
1459736_at 3.35E-03 5.88 Stk10* 
1417814_at 3.53E-03 1.33 Pla2g5 
1455564_at 3.53E-03 1.26 Bcr 
1435233_at 3.69E-03 1.11 Ncoa2 
1416123_at 4.61E-03 2.18 Ccnd2* 
1418152_at 5.13E-03 1.19 Nsbp1 
1429123_at 5.38E-03 1.68 Rab27a 
1449175_at 7.05E-03 1.74 Gpr65 
1426314_at 7.16E-03 1.33 Ednrb 
1428777_at 7.58E-03 1.41 Spred1 
1420555_at 7.77E-03 1.84 Alx3 
1429444_at 7.97E-03 1.72 Rasl11a 
1423059_at 8.25E-03 1.25 Ptk2 
1456220_at 8.46E-03 1.44 Fbxl7 
1428119_a_at 9.62E-03 1.34 Rap2c 
Oxidative 
stress 
   
1456082_x_at 1.30E-03 2.08 Cct4* 
1426990_at 2.71E-03 3.35 Cubn* 
1416421_a_at 3.08E-03 1.17 Ssb 
1423997_at 3.25E-03 1.11 Csde1 
1454624_at 3.83E-03 1.19 Dennd2a 
1448363_at 4.10E-03 1.17 Yap1 
1439457_x_at 5.75E-03 2.44 Atg12* 
1425451_s_at 5.76E-03 3.84 Chi3l3 /// Chi3l4* 
1418835_at 5.98E-03 1.59 Phlda1 
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1420788_at 6.89E-03 1.61 Klrg1 
1425450_at 7.89E-03 5.39 Chi3l4* 
1451005_at 8.04E-03 1.10 Sumo1 
1453928_a_at 9.53E-03 1.17 Ssb 
Extracellular 
matrix/transport 
  
1421462_a_at 1.63E-03 1.64 Lepre1 
1458524_at 1.64E-03 2.43 Fndc3a* 
1453124_at 2.08E-03 1.14 Tnpo3 
1431375_s_at 2.21E-03 1.13 Parva 
1433833_at 2.34E-03 1.07 Fndc3b 
1429540_at 2.75E-03 1.64 Cnfn 
1431004_at 2.90E-03 1.91 Loxl2 
1417902_at 2.93E-03 1.34 Slc19a2 
1450740_a_at 3.29E-03 1.07 Mapre1 
1420484_a_at 3.40E-03 3.55 Vtn* 
1458403_at 4.84E-03 1.90 Tnik 
1417847_at 5.03E-03 1.08 Ulk2 
1449563_at 6.60E-03 1.52 Cntn1 
1440799_s_at 7.31E-03 1.29 Farp2 
1436062_at 7.78E-03 1.31 Arcn1 
Protein 
synthesis 
   
1429303_at 3.65E-04 1.58 Zfp393 
1460006_at 3.71E-04 1.18 Atbf1 
1436392_s_at 4.23E-04 1.53 Tcfap2c 
1420650_at 5.64E-04 1.27 Atbf1 
1418820_s_at 7.25E-04 1.34 Zcchc10 
1423670_a_at 1.13E-03 1.07 Srpr 
1435664_at 1.28E-03 1.20 Zfp397 
1436938_at 1.51E-03 1.28 Rbms3 
1452932_at 1.73E-03 1.20 Zbtb7a 
1459393_at 3.04E-03 1.94 Tcfap2b 
1416469_at 3.23E-03 1.37 Luzp1 
1444679_at 6.55E-03 1.43 Bhc80 
1448760_at 7.17E-03 1.21 Zfp68 
1450080_at 7.19E-03 1.31 Cxx1c 
1452052_s_at 7.53E-03 1.19 Eif3s1 
1457834_at 7.56E-03 1.29 Yy1 
1424573_at 8.59E-03 2.24 Tmed5* 
1435870_at 9.02E-03 1.37 Sycp3 
1416224_at 9.02E-03 1.19 Zbtb17 
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1454846_at 9.60E-03 1.21 Utp15 
1456617_a_at 9.61E-03 1.23 Eif2s2 
Other    
1456746_a_at 1.92E-05 4.70 Cd99l2* 
1424782_at 3.84E-04 1.19 Tmem77 
1417776_at 5.55E-04 2.77 Azgp1* 
1450691_at 5.56E-04 1.17 Caskin2 
1456747_x_at 8.99E-04 2.22 Cd99l2* 
1426856_at 1.02E-03 1.26 Hsdl2 
1441455_at 1.08E-03 1.64 Arpp19 
1455111_at 1.32E-03 1.21 Yipf6 
1441137_at 1.66E-03 1.15 Bicc1 
1415704_a_at 1.66E-03 1.14 Cdv3 
1447943_x_at 1.95E-03 1.33 Yeats2 
1452479_at 2.06E-03 1.87 Copg2as2 
1418546_a_at 2.08E-03 1.25 Stambpl1 
1456141_x_at 2.12E-03 1.27 MGI:2389572 
1450534_x_at 2.17E-03 2.07 LOC56628* 
1422861_s_at 2.34E-03 1.59 Pdlim5 
1434291_a_at 3.00E-03 1.31 Serf1 
1425195_a_at 3.02E-03 1.20 Acat2 /// Acat3 
1458748_at 3.07E-03 2.08 Rbm27 
1431464_a_at 3.14E-03 1.14 Pmm2 
1433667_at 3.61E-03 2.38 Lgi3* 
1429447_at 4.61E-03 1.46 Evc2 
1447091_at 4.64E-03 1.72 Jmjd2c 
1425484_at 4.79E-03 1.37 Tox 
1419523_at 4.80E-03 3.12 Cyp3a13* 
1430893_at 5.01E-03 7.27 Mup1* 
1429216_at 5.46E-03 1.33 Paqr3 
1457763_at 5.62E-03 2.64 Gabrd* 
1449443_at 5.67E-03 1.17 Decr1 
1453644_at 6.12E-03 1.09 Obp1a 
1420719_at 6.46E-03 1.37 Tex15 
1436012_s_at 7.21E-03 1.33 Scrn2 
1435792_at 7.67E-03 1.98 Csprs 
1420367_at 8.19E-03 1.35 Denr 
1451122_at 9.02E-03 1.14 Idi1 
1453972_x_at 9.40E-03 1.51 Pparbp 
1431172_at 9.47E-03 1.95 Orc4l 
1424243_at 9.52E-03 1.18 Rwdd4a 
*, down-regulated ≥ 2-fold 
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Table 4.3. Genes up-regulated with p < 0.01 
 
Probeset ID p-value FC Gene symbol 
Apoptosis/Cell 
cycle 
   
1451781_at 2.08E-04 2.15  Nfatc2ip* 
1433438_x_at 2.38E-04 5.87  Mela* 
1421784_a_at 4.57E-04 1.07  Efna4 
1422254_a_at 4.96E-04 1.36  Dyrk1b 
1448510_at 9.23E-04 1.22  Efna1 
1419208_at 1.20E-03 1.83  Map3k8 
1426047_a_at 1.50E-03 1.41  Ptprr 
1432195_s_at 2.00E-03 1.13 Ccnl2 
1448212_at 2.11E-03 1.18  Tnfsf5ip1 
1456080_a_at 2.12E-03 1.31  Tde1 
1426829_at 2.61E-03 1.28  Rxrip110 
1460295_s_at 2.72E-03 1.33  Il6st 
1417574_at 2.78E-03 1.75  Cxcl12 
1426239_s_at 3.59E-03 1.19  Arrb2 
1436855_at 3.91E-03 1.31  Ptprs 
1457289_at 4.09E-03 1.18  Nr2e1 
1455669_at 4.44E-03 1.44  Wdr19 
1444271_at 4.99E-03 1.44  Anapc1 
1451967_x_at 5.23E-03 1.72  Kpnb1 
1428677_at 5.50E-03 1.30  Wdr73 
1424174_at 6.25E-03 1.25  Shkbp1 
1416027_at 6.29E-03 1.12 Pdcd6 
1432176_a_at 6.39E-03 1.42  Eng 
1423923_a_at 6.50E-03 1.36  Wdr8 
1450213_at 6.53E-03 1.64  Pde7b 
1433891_at 7.94E-03 1.12  Lgr4 
1437527_x_at 8.25E-03 1.28  Mcl1 
1451829_a_at 8.26E-03 1.41 Nf2 
1437192_x_at 8.48E-03 1.40 Vdac1 
1441755_at 8.81E-03 1.51  Mapk15 
1456278_x_at 9.08E-03 2.57  Gpr172b* 
1424294_at 9.25E-03 1.13  Ppp4r1 
1425588_at 9.70E-03 1.71  Ptprj 
Oxidative 
stress 
   
1425982_a_at 1.84E-04 2.06  Wrn* 
1417800_at 1.51E-03 1.58  Parp2 
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1431948_a_at 2.36E-03 1.17  Pank2 
1415735_at 4.39E-03 1.07  Ddb1 
1418699_s_at 5.42E-03 1.28  Fech 
1446461_at 5.90E-03 5.09  Sox5* 
1417184_s_at 6.01E-03 1.12  Hbb 
1428168_at 6.98E-03 1.13  Mpzl1 
1452230_at 7.02E-03 1.46  Dnajc10 
1416618_at 7.30E-03 1.33  Ppox 
1422627_a_at 7.39E-03 1.18  Mkks 
1425859_a_at 7.73E-03 1.10  Psmd4 
1456015_x_at 8.25E-03 1.10  Ndufv1 
1418172_at 8.77E-03 1.48  Hebp1 
1422715_s_at 9.04E-03 1.23  Acp1 
1418700_at 9.39E-03 1.22  Lias 
1417714_x_at 9.84E-03 1.85  Hba-a1 
Extracellular 
matrix/transport 
  
1431487_at 9.21E-06 2.21  Klc2* 
1451724_at 2.06E-04 1.18  Ankmy2 
1427044_a_at 4.89E-04 1.59  Amph 
1419764_at 8.82E-04 4.60  Chi3l3* 
1435009_at 1.11E-03 1.23  Slc9a6 
1416997_a_at 1.54E-03 1.25  Hap1 
1424735_at 2.92E-03 1.22  Slc25a25 
1416529_at 3.26E-03 1.28  Emp1 
1431646_a_at 4.09E-03 1.27  Stx6 
1460390_at 4.28E-03 1.30  Sorl1 
1450984_at 4.47E-03 1.16  Tjp2 
1421315_s_at 4.56E-03 1.11  Cttn 
1438559_x_at 4.80E-03 1.58  Slc44a2 
1434801_x_at 6.01E-03 1.12  Slc25a5 
1425731_at 6.73E-03 1.55  Ankrd24 
1423550_at 7.02E-03 1.29  Slc1a4 
1416065_a_at 8.27E-03 2.17  Ankrd10* 
1427260_a_at 9.08E-03 1.21  Tpm3 
1417750_a_at 9.98E-03 1.38  Slc25a37 
Protein 
synthesis 
   
1455407_at 2.40E-03 1.40  Zfp236 
1428869_at 2.87E-03 1.11  Nolc1 
1451101_a_at 3.08E-03 1.06  Rps28 
1427309_at 3.54E-03 1.21  Pars2 
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1452780_at 5.13E-03 1.16  Gtf3c2 
1428494_a_at 5.59E-03 1.08  Polr2i 
1421986_at 6.32E-03 1.36  Eif4e2 
1455222_a_at 6.72E-03 1.22  Ubp1 
1452371_at 7.48E-03 1.26  Sfrs11 
1423687_a_at 7.71E-03 1.12  Man2c1 
1457293_at 8.67E-03 1.26  Zbtb4 
1427500_at 9.23E-03 1.39  Spcs1 
1435071_at 9.73E-03 1.34  Zfyve1 
Other    
1418069_at 2.69E-04 2.74  Apoc2* 
1416222_at 9.47E-04 1.19  Nsdhl 
1424335_at 1.10E-03 1.23  Ppcdc 
1440888_at 2.10E-03 1.87 Oxtr 
1451755_a_at 2.52E-03 1.35  Apobec1 
1424304_at 3.03E-03 1.96  Tpcn2 
1422703_at 3.18E-03 1.17  Gyk 
1450028_a_at 3.56E-03 1.30  Lancl2 
1448491_at 3.74E-03 1.21  Ech1 
1428166_at 3.79E-03 1.24  Cdan1 
1448549_a_at 4.72E-03 1.25  Dpagt1 
1448237_x_at 4.94E-03 1.08  Ldh2 
1440157_at 6.04E-03 2.79  Scml4* 
1451308_at 6.10E-03 1.25  Elovl4 
1423418_at 6.15E-03 1.16  Fdps 
1426440_at 6.31E-03 1.15  Dhrs7 
1436689_a_at 6.58E-03 1.33  Aldh9a1 
1443636_at 6.93E-03 1.46  Abcb9 
1452361_at 7.00E-03 1.30  Rnf20 
1421155_at 7.12E-03 1.22  B3galt6 
1450107_a_at 7.18E-03 1.32  Renbp 
1452969_at 7.18E-03 1.34  Atp2b1 
1452708_a_at 7.51E-03 1.15 Luc7l 
1427956_at 8.07E-03 1.16 Pcgf1 
1458421_at 9.00E-03 2.90  Kcnq3* 
*, up-regulated ≥ 2-fold  
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Figure 4.13.  Categorical analysis.  Pie chart shows the classification the 221 significantly 
regulated genes (p < 0.01) into functional categories based on Gene Ontology (GO) descriptors 
and literature searches.  A total of 60% can be classified in neurodegeneration-associated 
categories of apoptosis/cell cycle, oxidative stress, and extracellular matrix/transport. 
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Table 4.4. Functional categorization of genes regulated with p<0.01; up- or down-regulated ≥ 2-
fold in the Hq/Y mutant mouse OE compared to +/Y controls. 
 
Gene name  Gene 
Symbol 
P-Value Fold 
Change 
GENES DOWN-REGULATED ≥ 2-FOLD 
     
Apoptosis/cell cycle 
programmed cell death 8 Pdcd8 7.29E-05 - 4.72 
Serine/threonine kinase 10 (Stk10), mRNA Stk10 3.35E-03 - 5.88 
cyclin D2 Ccnd2 4.61E-03 - 2.18 
     
Oxidative stress 
chaperonin subunit 4 (delta) Cct4 1.30E-03 - 2.08 
cubilin (intrinsic factor-cobalamin receptor) Cubn 2.71E-03 - 3.35 
autophagy-related 12 (yeast) Atg12 5.75E-03 - 2.44 
chitinase 3-like 3 /// chitinase 3-like 4 (Ym1/2) Chi3l3 /// 
Chi3l4 
5.76E-03 - 3.84 
chitinase 3-like 4 (Ym1/2) Chi3l4 7.89E-03 - 5.39 
    
Extracellular matrix/transport    
fibronectin type III domain containing 3a Fndc3a 1.64E-03 - 2.43 
vitronectin Vtn 3.40E-03 - 3.55 
     
Protein synthesis 
transmembrane emp24 protein transport 
domain containing 5 
Tmed5 8.59E-03 - 2.24 
     
Other 
Cd99 antigen-like 2 Cd99l2 1.92E-05 - 4.70 
alpha-2-glycoprotein 1, zinc Azgp1 5.55E-04 - 2.77 
Cd99 antigen-like 2 Cd99l2 8.99E-04 - 2.22 
MHC (A.CA/J(H-2K-f) class I antigen LOC56628 2.17E-03 - 2.07 
RNA binding motif protein 27 Rbm27 3.07E-03 - 2.08 
leucine-rich repeat LGI family, member 3 Lgi3 3.61E-03 - 2.38 
cytochrome P450, family 3, subfamily a, 
polypeptide 13 
Cyp3a13 4.80E-03 - 3.12 
major urinary protein 1 Mup1 5.01E-03 - 7.27 
Gamma-aminobutyric acid (GABA-A) 
receptor, subunit delta 
Gabrd 5.62E-03 - 2.64 
     
GENES UP-REGULATED ≥ 2-FOLD 
     
Apoptosis/cell cycle 
nuclear factor of activated T-cells, Nfatc2ip 2.08E-04 2.15 
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cytoplasmic, calcineurin-dependent 2 int. ptn. 
melanoma antigen Mela 2.38E-04 5.87 
G protein-coupled receptor 172B Gpr172b 9.08E-03 2.57 
     
Oxidative stress 
Werner syndrome homolog (human) Wrn 1.84E-04 2.06 
SRY-box containing gene 5 (Sox5), mRNA Sox5 5.90E-03 5.09 
     
Extracellular matrix/transport 
kinesin light chain 2 Klc2 9.21E-06 2.21 
chitinase 3-like 3 Chi3l3 8.82E-04 4.60 
ankyrin repeat domain 10 Ankrd10 8.27E-03 2.17 
     
Protein synthesis 
     
Other 
apolipoprotein C-II Apoc2 2.69E-04 2.74 
sex comb on midleg-like 4 (Drosophila) Scml4 6.04E-03 2.79 
potassium voltage-gated channel, subfamily Q, 
member 3 
Kcnq3 9.00E-03 2.90 
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Table 4.5.  EASE analysis 
      UP-REGULATED GENES 
Category 
# of 
related 
categories 
List 
hits/list 
total 
EASE 
score 
Cellular Component 
nucleus/nuclear pore 5 96/300 2.1E-03 
endoplasmic reticulum 1 23/300 5.5E-03 
mitochondrion 1 33/300 0.016 
Biological Process 
coenzyme-prosthetic group 
metabolism/porphyrin metabolism 
5 11/303 0.013 
RNA processing/editing 4 18/303 0.014 
Molecular Function 
transferase activity 2 10/308 2.9E-03 
intracellular transporter activity 1 4/308 0.024 
 
     DOWN-REGULATED GENES 
Category 
# of 
related 
categories 
List 
hits/list 
total 
EASE 
score 
Cellular Component 
nucleoplasm/transcription factor complex 2 30/278 0.021 
Biological Process 
cytoskeletal organization and biogenesis 4 20/276 8.6E-04 
regulation of transcription/DNA-dependent 4 55/276 1.7E-03 
neurogenesis/CNS development/axon 
guidance 
4 19/276 3.9E-03 
Molecular Function 
nucleic acid binding 2 80/292 0.010 
protein carrier activity 1 3/292 0.037 
transmembrane receptor protein kinase 
activity 
1 6//292 0.036 
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Molecular validation of gene regulation using real time RT-PCR 
 We utilized real-time RT-PCR to determine the expression levels of Pdcd8.  The gene 
was significantly down-regulated in the Hq/Y mutant mice compared to +/Y controls (Table 4.6).  
This both validated our GeneChip data for this gene as well as extended results from a previous 
report (Klein et al. 2002) in the whole brain and retina, where an 80% down-regulation of the 
gene was observed in the mutants.  
 Genes were critically selected for real time RT-PCR validation based on their biological 
relevance to the study, p-values < 0.01, and a robust mean hybridization signal (>100) in all six 
animals.  We used real time RT-PCR to determine the direction and magnitude of changes in 
expression levels for the genes Pdcd8, Cct4 (chaperonin subunit 4, delta; response to stress), and 
Loxl2 (lysyl oxidase like-2; apoptosis), which were significantly down-regulated, and Amph 
(amphiphysin I; synaptic vesicle recycling), Parp2 (poly ADP-ribose polymerase-2; apoptosis), 
and Cxcl12 (chemokine (C-X-C motif) ligand 12 or stromal cell derived factor-1 alpha; 
chemotaxis), which were significantly up-regulated.  We confirmed that each real-time RT-PCR 
reaction resulted in only one product by determining the predicted melting point for each 
amplicon and by confirming that this matched that obtained by melting curve analysis.  We 
further confirmed the presence of a single amplicon of the predicted size by agarose gel 
electrophoresis.  In all cases, the direction of change between the microarray data and the real 
time RT-PCR data was the same, and the p-values for the real time RT-PCR were < 0.05 for all 
except Loxl2, for which the p-value = 0.05 (Table 4.6). 
 The results of our analyses validate the use of the Harlequin mutant mouse model at the 
cellular and molecular levels for fundamental studies of neurodegeneration in the murine 
olfactory system and suggest mechanisms underlying this olfactory degeneration and associated 
tissue remodeling. 
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 Table 4.6.  Real-time RT-PCR validation of GeneChip data 
 
Gene 
Symbol 
GeneChip 
p-value 
GeneChip 
fold-
change 
Real-time 
RT-PCR 
p-value 
Real-time 
RT-PCR 
fold-change 
Pdcd8 7.3E-05 ↓4.7 2.0E-03 ↓2.6 
Cct4 1.3E-03 ↓2.1 9.7E-03 ↓1.3 
Loxl2 2.9E-03 ↓1.9 5.2E-02 ↓1.4 
Amph 4.9E-04 ↑1.6 2.4E-02 ↑1.2 
Parp2 1.5E-03 ↑1.6 4.0E-02 ↑1.2 
Cxcl12 2.8E-03 ↑1.7 1.0E-04 ↑1.5 
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Discussion 
 
 In this paper, I have demonstrated the occurrence of oxidative damage to mOSNs and an 
increase in apoptosis in the OE as a result of a single mutation in the Pdcd8 gene in the 
Harlequin mutant mouse.  Our bioinformatics analysis identified specific genes involved in 
oxidative stress, apoptosis and other neurodegenerative processes that provided insight into the 
underlying neurodegenerative mechanisms. 
 The protein product of the Pdcd8 gene, AIF, is a mitochondrial-resident flavoprotein 
under non-apoptotic conditions (Hong et al. 2004).  In the OE of control mice, AIF 
immunoreactivity was punctate in appearance and located primarily in the dendritic and 
perinuclear regions of mOSNs, coinciding with the localization of mitochondria in mOSNs as 
shown in electron microscopic studies (Naguro and Iwashita 1992).  In contrast, most OSNs in 
the Harlequin mutant mice lacked AIF expression.  This result was anticipated based on a 
previous report in which an 80% reduction in both the Pdcd8 transcript and AIF protein was 
observed in the retina and various brain regions (Klein et al. 2002).  The occasional clusters of 
AIF-positive cells, many of which were mOSNs, in the OE of the Harlequin mutant mice 
exhibited a very different sub-cellular localization pattern that appeared diffusely cytosolic.  This 
indicates that AIF protein was translocated out of mitochondria during the degenerative process 
under conditions of oxidative stress.  AIF is key to maintaining mitochondrial oxidative 
homeostasis under physiological conditions (Vahsen et al. 2004) and, in pre-apoptotic cells, it 
may be translocated into the cytosol prior to entering the nucleus (Hong et al. 2004; Modjtahedi 
et al. 2006). 
 Oxidative DNA damage occurs in mitochondria of aging neurons and those undergoing 
neurodegeneration (Sullivan et al. 2004).  The Harlequin mutation results in decreased levels of 
AIF protein as well as substantially reduced oxidoreductase activity, leading to elevated 
mitochondrial oxidative stress, identified by DNA damage in various brain regions (Klein et al. 
2002; Stringer et al. 2004; Vahsen et al. 2004).  Previous studies from our laboratory and others 
have described the occurrence of oxidative macromolecular damage in the olfactory system in 
aging and neurodegenerative disease, as shown by increased levels of protein oxidation, 
including carbonylation, 3-nitrotyrosylation, and lipofuscin deposition, in the OBs of aging mice 
as well as increased DNA damage in OSNs and OBs from Alzheimer’s disease patients (Getchell 
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et al. 2003a; Perry et al. 2003; Poon et al. 2005b; Poon et al. 2006b; Vaishnav et al. 2006).  In the 
Harlequin mice, we found evidence for both protein and DNA oxidative damage.  The 
accumulation of lipofuscin, a so-called “age pigment” of postmitotic cells that is a marker of 
primarily undegradable oxidized protein (Keller et al. 2004; Terman et al. 2006), has been 
previously observed in aging mice primarily in the foot processes of OE sustentacular cells and 
in OB mitral/tufted cells (Naguro and Iwashita 1992; Vaishnav et al. 2006).  I have demonstrated 
a similar pattern of intense autofluorescent lipofuscin deposits throughout the OE, particularly in 
the foot processes of sustentacular cells, as well as in mitral/tufted cells in the OBs of the 
Harlequin mutant mice.  I have also demonstrated the presence of elevated DNA damage, as 
evidenced by increased 8OHdG, in mOSNs in the OE and in mitral/tufted cells of the OBs of the 
Harlequin mice, as previously reported in the brains of Harlequin mice (Klein et al. 2002; 
Stringer et al. 2004).  Taken together, the evidence that I have provided for oxidative 
macromolecular damage in the OE and OB of the Harlequin mice that results from a single 
mutation in the Pdcd8 gene make these mice an attractive model for studies of oxidative-stress 
associated neural changes in the olfactory system. 
 Oxidative macromolecular damage predisposes neurons to cell death through the release 
of pro-apoptotic factors, including AIF and cytochrome c, that activate caspase-independent and 
caspase-dependent cell death pathways (Annunziato et al. 2003; Culmsee and Landshamer 2006; 
Getchell et al. 2005; Holcomb et al. 1995).  Caspase-3 and its active form cleaved caspase-3 are 
key initiators of the apoptotic cascade in mOSNs as a result of oxidative stress and OBX 
(Borders et al. 2006; Cowan and Roskams 2004; Cowan et al. 2001; Getchell et al. 2005).  
Cleaved caspase-3 is an effector of neuronal apoptosis in the cerebellum and retina of Harlequin 
mice as well as in neuronal cell culture models in which Pdcd8 is mutated (Cheung et al. 2006; 
Klein et al. 2002).  The marked increase in cleaved caspase-3-positive cells in the OE of the 
mutant mice demonstrated that the Harlequin mutation can lead to apoptotic cell death in the OE, 
possibly as a result of increased neuronal vulnerability due to oxidative DNA damage.  The 
increased numbers of macrophages in the OE of the Harlequin mutant mice (e.g., Figure 4.3) was 
also indicative of increased numbers of apoptotic OSNs, which initiate a molecular cascade in 
which chemokine release causes the infiltration of macrophages that phagocytose apoptotic 
OSNs (Borders et al. 2006; Getchell et al. 2006; Getchell et al. 2002b; Kwong et al. 2004; 
Suzuki et al. 1995).  The changes in tissue architecture, as observed in hematoxylin and eosin- 
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and α-laminin-stained sections, further demonstrate the degenerative changes occurring in the 
OE that are similar to previous observations of cytoskeletal remodeling in the degenerating OE at 
short time points post-OBX as reported by our laboratory (Getchell et al. 2006; Getchell et al. 
2005; Nan et al. 2001). 
 The statistical analysis of our microarray data showed that the single gene mutation in 
Pdcd8 resulted in highly significant changes in a select group of genes.  Our categorical analysis 
provided further confirmation that the mutation resulted in changes in several oxidative stress- 
and neurodegeneration-associated genes in the OE.  The majority of the genes regulated in the 
Harlequin mutant mouse OE were involved primarily in oxidative stress, apoptosis/cell cycle, 
and/or extracellular matrix/transport, complementing our cellular observations and supporting 
our validation of the Harlequin mouse model for fundamental olfactory neurobiological studies. 
From among the 221 genes significantly up- or down-regulated with p < 0.01 in the OE of the 
Harlequin mice, I selected six genes for validation with RT-PCR; these genes were particularly 
relevant to our cellular results showing increased oxidative stress, apoptosis, and 
cytoarchitectural disruption.  Three of these genes (Pdcd8, Cct4, and Loxl2) were down-
regulated, and three (Amph, Parp2, and Cxcl12) were up-regulated; the direction and relative 
magnitude of gene regulation in the microarray results were validated by the RT-PCR results. 
 Pdcd8 (GO category, apoptotic mitochondrial changes) was significantly down-regulated 
by 80% in our microarray analysis, confirming our immunohistochemical data showing a 
substantial reduction in the expression of AIF protein in the OE.  Two other down-regulated 
genes, Cct4 (GO category, unfolded protein binding) and Loxl2 (GO category, oxidoreductase 
activity), are also related to stress responses and oxidative stress.  Cct4 encodes the delta subunit 
of the chaperonin-containing tailless complex polypeptide (CCT), a large (> 900 kD) multi-
subunit complex that mediates cytosolic protein folding (Dunn et al. 2001).  The CCT4 subunit is 
involved in binding to and folding cytosolic proteins such as the cytoskeletal proteins actin and 
tubulin and several cell cycle-related proteins (Spiess et al. 2004).  An autosomal recessive 
mutation in Cct4 causes a hereditary peripheral sensory neuropathy in rats that is characterized 
by pronounced apoptosis in the dorsal root ganglion and loss of cutaneous sensory fibers (Hsu et 
al. 2004; Lee et al. 2003).  Down-regulation of Cct4 in the OE may compromise the proper 
folding of actin and tubulin, leading to disruption of cytoskeletal integrity, axonal transport and 
pathway finding, and of cell cycle proteins, leading to decreased neurogenesis.  The presence of 
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improperly folded cytosolic proteins may induce additional oxidative stress (e.g., (Sitia and 
Molteni 2004).    Loxl2 is a member of the lysyl oxidase (LOX) family that includes LOX, 
LOXL, LOXL2, LOXL3, AND LOXL4 (Molnar et al. 2003).  These copper-containing amine 
oxidases, which are involved in extracellular matrix remodeling, cellular senescence, 
development, and migration (Csiszar 2001), have been localized in Purkinje cells of the 
cerebellum and in the retinal pigment epithelium and ganglion cells of the retina (Hayashi et al. 
2004).  Specifically, LOXL2 interacts with and stabilizes the transcription factor SNAIL, which 
in turn down-regulates epithelial genes such as Cdh1 (cadherin 1, E-cadherin) and up-regulates 
mesenchymal genes such as Vim (vimentin; (Peinado et al. 2005), both of which are key 
molecules regulating the growth and axonal targeting of OSNs (Akins and Greer 2006a; Akins 
and Greer 2006b).  Also, regulation of a SNAIL homologue (Snai2) and Cdh1 have been 
implicated in OE remodeling induced by OBX (Getchell et al. 2005).  Consequently, a down-
regulation of Loxl2 in the OE of the Harlequin mice may be associated with increased apoptosis, 
decreased neurogenesis, and/or cytoarchitectural changes in the tissue (Csiszar 2001; Molnar et 
al. 2003; Peinado et al. 2005). 
 Among the validated genes up-regulated in the OE of the Harlequin mice, Amph (GO 
category, synaptic vesicle endocytosis), which is particularly enriched in nerve terminals in the 
brain and retina, encodes a key protein involved in clathrin-mediated endocytosis and synaptic 
vesicle formation (Wigge and McMahon 1998).  AMPH is a member of the 
Bin1/amphiphysin/Rvs167 (BAR) domain protein family (Ren et al. 2006), which is involved in 
a variety of fundamental cellular processes and function by sensing the curvature of cellular 
membranes and recruiting/activating GTPases (Ren et al. 2006).  The main physiological ligands 
for AMPH are dynamin (DNM1) and synaptojanin, with which it functions cooperatively in 
clathrin-mediated endocytosis (Grabs et al. 2000; Yoshida and Takei 2005).  The GTPase DNM1 
is co-localized with clathrin in cell bodies, dendrites and dendritic knobs of OSNs (Rankin et al. 
1999) and forms a stable complex with synaptojanin and endophilin 3 in the synaptic termini of 
OSNs (Faire et al. 1992; Sugiura et al. 2004).  We previously reported the identification and age-
associated down-regulation of DNM1 in murine olfactory bulbs and brains (Poon et al. 2005b; 
Poon et al. 2006b) as well as the oxidative stress-associated carbonylation of this protein in 
olfactory bulbs (Vaishnav et al. 2006).  The down-regulation and likely impairment of DNM1 
function that we have shown to result from oxidative stress may cause a compensatory up-
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regulation of Amph expression.  Parp2 (GO category, DNA repair) encodes the nuclear enzyme 
PARP2, which is one of 18 members of the poly(ADP-ribose) polymerase (PARP) superfamily 
(Huber et al. 2004).  PARP2 and its partner PARP1 detect oxidative stress-induced breaks in 
DNA and initiate single strand break repair and base excision repair pathways by ADP-
ribosylating DNA-binding proteins (Bouchard et al. 2003; Huber et al. 2004).  If the damage to 
DNA is extensive, PARP2 and PARP1 initiate apoptosis via the caspase-independent pathway by 
triggering AIF release from mitochondria (Hong et al. 2004).  Our laboratory has previously 
reported the up-regulation of Parp2 in the senescence-accelerated mouse (SAM) model of aging, 
and the localization and an apparent increase of PARP1 in olfactory nerve bundles in these mice 
(Getchell et al. 2004).  The up-regulation of Parp2 in the OE of Harlequin mutant mice was 
consistent with the elevated neuronal DNA damage demonstrated by 8OHdG due to increased 
oxidative stress.  Also, PARP2 activation may be responsible for initiating the cytosolic 
translocation of AIF, resulting in the diffuse pattern of immunoreactivity that we observed in the 
occasional clusters of AIF-immunoreactive OSNs in the Harlequin mutant mice.  Cxcl12 (GO 
category, cell migration) encodes the CXC motif-containing chemokine CXCL12 which is a 
chemoattractant for a variety of immune system cells including monocytes (Blades et al. 2002) 
as well as OB progenitor/stem cells (Tran et al. 2004).  CXCL12, through its receptor CXCR4, 
also plays a significant physiological role in the nervous system by guiding survival, 
development, targeting and neurotransmission of several neuronal subtypes including retinal 
ganglion cells, retinal pigment epithelial cells and cerebellar granule cells (Bhutto et al. 2006; 
Klein and Rubin 2004; Li et al. 2005).  Cxcl12 is significantly up-regulated at 48 h following 
OBX, presumably as part of mechanism by which macrophages are recruited to the OE (Getchell 
et al. 2006).  In the OE of the Harlequin mutant mouse, the increased numbers of macrophages 
that we observed may be due in part to the apoptosis-induced up-regulation of Cxcl12. 
 Our EASE analysis highlighted the cellular components involved and the biological 
pathways which were downstream to the Harlequin mutation in the OE.  An integrated picture 
emerged from this analysis: the primary cellular components, in which a proportionately higher 
number of genes were up-regulated, were the nucleus, endoplasmic reticulum, and mitochondria, 
all three of which are major players in oxidative stress responses and apoptosis.  Among down-
regulated genes, we found an over-representation of the categories of neurogenesis and 
cytoskeletal organization, both of which are critical processes in the maintenance of the normal 
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adult OE.  Down-regulated neurogenesis has been reported in the OE, OB, and subventricular 
zone in old rats and mice (Enwere et al. 2004; Loo et al. 1996); in the OE of the Harlequin 
mutant mouse, decreased neurogenesis-related gene expression may reflect the oxidative-stress-
modified environment, indicated by increased amounts of 8OHdG and accumulation of 
lipofuscin, that has been postulated to account for reduced neurogenesis in the aged brain (Limke 
and Rao 2003).  We have previously reported the down-regulation of key cytoskeletal genes 
indicative of cytoskeletal remodeling in response to OBX-induced OSN apoptosis (Getchell et al. 
2005); in the OE of the Harlequin mutant mouse, the down-regulation of these genes might 
reflect increased apoptosis as well as the apparent disorganization of the OE cytoarchitecture. 
 In summary, I have introduced and provided novel evidence validating the Harlequin 
mutant mouse as a model for studies of oxidative stress-associated olfactory neurodegeneration 
at the cellular and molecular levels.  The cellular studies demonstrated that the Harlequin 
mutation in the Pdcd8 gene resulted in decreased levels and altered distribution of AIF protein in 
mOSNs, increased oxidative DNA damage in mOSNs and other cells in the OE, an increased 
number of OE cells undergoing apoptosis, and cytoarchitectural disorganization.  Our molecular 
studies confirmed the reduction in Pdcd8 expression in the OE and identified genes whose 
significant differences in expression levels in the mutant and wild type mice contribute to and 
result from elevated oxidative stress and apoptosis.  These integrated cellular and molecular 
analyses provide direction for future mechanistic studies using Harlequin mice as a model of 
oxidative stress- associated olfactory neurodegeneration. 
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CHAPTER FIVE 
 
GENERAL DISCUSSION 
 
 
 The overall aim of our study was to gain fundamental insight into molecular events 
associated with olfactory aging and neurodegeneration.  The first specific aim was to test the 
hypothesis that oxidative stress is associated with aging of the olfactory system.  To address this 
question, I performed a comparative proteomic analyses, using 2-dimensional gel 
electrophoresis, of the olfactory epithelium (OE) and olfactory bulb (OB) of old (20-month old) 
and young (1.5-month old) mice with further analysis of selected proteins at the mRNA level 
using real-time RT-PCR.  Nine proteins in the OE and 20 in the OB were differentially expressed 
in old and young mice, demonstrating an altered proteomic profile of the aged murine olfactory 
system.  The proteins identified by mass spectrometry were classified under three broadly-
defined functional categories (summarized in Figure 5.1A), namely (a) metabolism, (b) 
transport/synaptic and (c) oxidative stress.  The expression of a number of the identified proteins 
differed at the protein level but not at the mRNA level, suggesting the involvement of post-
transcriptional mechanisms of protein regulation.  Protein, DNA/RNA and lipid oxidation and 
consequent cellular damage can occur due to elevated oxidative stress.  While damaged 
molecules can be repaired, replaced or removed from the affected cells in most tissues, the aging 
brain has been shown to be particularly susceptible oxidative damage, partly due to the lack of 
neuronal replacement and a decline in proteasomal activity in aging (Keller et al. 2004; Poon et 
al. 2004a; Szweda et al. 2003).  This can result in the accumulation of oxidized and inactive 
proteins as insoluble aggregates inside the cell, further hindering cellular function (Keller et al. 
2004; Szweda et al. 2003).  Whether protein oxidation is a key mediator of olfactory 
degeneration, and if so, to what extent, was largely unknown, and formed the basis of my second 
specific aim. 
 The second specific aim was to test the hypothesis that the olfactory system accumulates 
oxidative stress-mediated macromolecular damage over time, predisposing it to 
neurodegeneration.  To address this aim, I used redox proteomics to quantify total and specific 
protein carbonylation and identify differentially carbonylated proteins in OBs of 1.5- and 20-
122 
month old mice. While many recent advances have been made in the understanding of molecular 
interactions in olfactory neurobiology using genomics platforms, the field has remained naïve to 
proteomics prior to the results reported here. This study is the first to apply proteomics in the 
aging olfactory system to identify differentially regulated proteins as well as proteins which have 
been post-translationally modified. The novel results described showed that oxidative stress-
associated protein damage is a key player at the molecular level in the cellular pathology 
underlying olfactory aging. The identities of the oxidized proteins were of key metabolism, 
transport/synaptic and oxidative stress-associated proteins, suggesting that these processes may 
be altered in the aging olfactory system (Figure 5.1B). Two types of protein oxidation: 
carbonylation and nitration were up-regulated with aging in the OB, demonstrating that there is 
an imbalance in oxidant-antioxidant levels. Further, the observation of elevated lipofuscin in 
OBs of old mice demonstrated that there was increased aggregation of proteins due to excessive 
oxidation and/or inefficient removal of these damaged proteins. Up-regulation and oxidation of 
the oxidative stress-response protein ferritin heavy chain corresponded with the increased 
lipofuscin in mitral/tufted cells, occurring incrementally over time.  Aldolase 1, an oxidized 
protein, was localized in astrocytes of the granule cell layer.  These results showed that specific 
carbonylated proteins, including those in mitral/tufted neurons and astrocytes, and nitrated 
proteins in the vasculature, are molecular substrates of age-related olfactory dysfunction.  
 Mitral/tufted cells, certain astrocytes and endothelial cells were targets of protein 
oxidation in the OB. Interestingly, granule cells and periglomerular cells, both of which are 
replaced by neurogenesis, did not appear to be directly affected by oxidative stress in our studies. 
Mitral/tufted cells, in contrast, are amitotic and not replaced, which would explain the 
accumulation of oxidized proteins over time. Nevertheless, I would not rule out the possibility of 
reduced neurogenesis also occurring due to oxidative stress, and a detailed pulse-chase in-vivo 
experiment could be designed in a follow-up study to assess changes in steady-state levels of 
protein oxidation in various cell types over time. Further, cell-type specific antioxidant 
responses, as well as protein clearance efficiency over time would have to be measured critically 
in future studies.   
 In summary, the results from specific aims 1 and 2 clearly demonstrated the presence of 
oxidative stress in the aging OB and identified specific protein and cellular targets of oxidative 
damage.
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Figure 5.1.  Venn diagrams showing broadly-defined functional relationships of proteins 
identified using proteomics. A, Proteins whose steady-state levels were significantly up- or 
down-regulated in the OE/OB of 20-month old mice compared to 1.5-month old mice. B, 
Proteins that were specifically carbonylated in the OBs of 20-month old and/or 1.5-month old 
mice. 
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 The aging mice were raised in controlled, sterile, pollutant-free environments, so it may 
be assumed that the only major factor differing between them and their younger cohorts was age. 
Consequently, the majority of the oxidative stress experienced by these mice would likely be of 
endogenous origin. Although other studies have evaluated the role of exogenous and endogenous 
oxidants in the brain (Korolainen et al. 2002; Perluigi et al. 2005; Pocernich et al. 2005; Poon et 
al. 2006b; Sultana et al. 2005) and the olfactory system (Perry et al. 2003), our current study is 
the first to systematically identify the proteins oxidized by endogenous oxidative stress in the 
olfactory system.  Future studies using the proteomics platform to identify and characterize 
proteins oxidized in olfactory system due to exogenous oxidants would be an excellent 
complement to the work described here.  
 With progressive oxidative stress-associated protein damage clearly emerging as a 
hallmark of aging in the olfactory system, the third specific aim was to test the hypothesis that 
elevated oxidative stress in the olfactory system results in apoptosis/neurodegeneration.  To 
successfully address this aim, we needed to identify a mouse model exhibiting elevated 
endogenous oxidative stress. Majority of the endogenous oxidants known are by-products of 
normal mitochondrial metabolism, and their levels increase as mitochondrial efficiency declines 
with aging (Sastre et al. 2003). The mitochondrial/free radical theory of aging proposes that 
elevated oxidative stress is a causative factor of the neurodegenerative changes associated with 
aging as well as age-associated disorders like Alzheimer’s disease (Pollack and Leeuwenburgh 
2001; Sastre et al. 2003). The Harlequin mouse, in which a defined mutation in a mitochondrial 
protein results in a dramatic decrease in mitochondrial metabolic activity, associated elevated 
oxidative stress and progressive neurodegeneration (Culmsee and Landshamer 2006; Klein et al. 
2002; Vahsen et al. 2004), was chosen for our study of the effects of elevated 
physiological/endogenous oxidative stress in the olfactory system. Here, I have reported the first 
characterization of the Harlequin mouse as a model for olfactory neurodegeneration associated 
with elevated oxidative stress, apoptosis and cytoskeletal reorganization occurring as early as 6 
months of age. 
 The Harlequin mutant mouse carries an X-linked recessive mutation in the Pdcd8 gene 
(Hq mutation) and is a model of progressive oxidative stress-induced neurodegeneration in the 
cerebellum and retina (Klein et al. 2002).  To determine whether the Harlequin mutant mouse 
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would be a suitable model of oxidative stress-associated olfactory neurodegeneration, we 
investigated cellular and molecular changes in the OE of 6-month old male Harlequin mice 
compared to their littermate controls.  Pronounced cytoskeletal changes, including laminar 
disorganization, were evident in the OE and to a lesser extent in the OB.  Punctate 
immunoreactivity for the protein product of Pdcd8, apoptosis-inducing factor (AIF), was 
localized in dendrites of mature olfactory sensory neurons (mOSNs) in control mice but was 
seldom detected in Harlequin mice, as expected.  The Harlequin mice also exhibited increased 
immunoreactivity for the oxidative DNA damage marker 8-hydroxydeoxyguanosine in mOSNs, 
increased number of apoptotic cells in the OE, and increased macrophage infiltration.  The 
cellular results were confirmed and extended by microarray analysis, demonstrating that Pdcd8 
mRNA expression was down-regulated 80% in the OE of Harlequin vs. control mice.  Most of 
the significantly regulated genes were functionally classified into oxidative stress, apoptosis/cell 
cycle and/or extracellular matrix/transport-associated categories.  Bioinformatics analysis 
indicated that significantly over-represented functional categories in Harlequin mice included up-
regulated mitochondrial genes, and down-regulated cytoskeletal organization- and neurogenesis-
related genes.   
 Mechanistically, the Harlequin mouse has given us considerable insight into the events 
underlying oxidative-stress associated olfactory degeneration. The model shown in Figure 5.2 is 
an illustration of the mechanism I have proposed, by which the Hq mutation, resulting in 
decreased AIF and mitochondrial impairment, interacts with progressing age to promote 
increased oxidative stress-associated oxidative DNA and protein damage and apoptosis of 
olfactory sensory neurons.  As illustrated in Figure 5.2, AIF is expressed in mitochondria in the 
dendrites and supranuclear region of mOSNs in healthy control mice and is down-regulated by 
80% in Harlequin mouse OE due to a mutation in the Pdcd8 gene.  Consequently, mitochondria 
would be less efficient, resulting in an increase in mitochondrial oxidative stress and associated 
DNA damage. Interestingly, the DNA damage observed in the 6-month old Harlequin mouse OE 
was primarily in the mitochondria, mainly in the mOSNs.  Lipofuscin aggregates, typifying 
excessive protein oxidation, were also present throughout the OE of the Harlequin mice. The 
oxidative DNA and protein damage observed in Harlequin mouse mOSNs would suggest an 
increase in their susceptibility to apoptotic cell death.  Certain mOSNs in the Harlequin mouse 
OE exhibited diffuse cytosolic AIF immunoreactivity, suggesting translocation of AIF out of the 
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mitochondria in response to elevated oxidative stress and DNA damage.  AIF may partner with 
PARP2 (the mRNA for which was significantly up-regulated in the Harlequin mouse OE) and 
PARP1 to initiate caspase-independent apoptosis if DNA damage were extensive; or could be 
sequestered in the cytosol by HSP70 to allow for DNA repair and cell survival.  The concurrent 
occurrence of frequent of cleaved-caspase-3 positive cells in the OE of the Harlequin mice 
demonstrated that caspase-dependent mechanisms of apoptosis were being activated in parallel.  
Figure 5.3 expands on our model in Figure 5.2, to include the cross-cellular communication 
between mOSNs, macrophages and mitral/tufted cells and illustrate the postulated roles of the 
protein products of significantly regulated genes selected from our microarray study.  Lower 
levels of available chaperonin, as indicated by down-regulated Cct4, would be another 
contributing factor to the oxidative stress-associated protein aggregation observed in the OE/OB.  
In addition, macrophage/microglial infiltration was observed in both the Harlequin mouse OE as 
well as the OB, possibly functioning to scavenge apoptotic olfactory neurons, including mOSNs. 
The chemokine CXCL12, which is known to be secreted by macrophages could be another key 
player in determining the fate of mOSNs, namely, survival vs. death.  Synaptic communication 
between mOSNs and mitral/tufted cells, may also be hindered, with several key synaptic genes 
(e.g. amphiphysin) among the significantly regulated genes.  The down-regulation of the growth 
and axonal targeting-associated Loxl2 would further impair cross-cellular communication and 
result in increased apoptosis, decreased neurogenesis, and/or cytoarchitectural changes in the 
tissue 
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Figure 5.2.  This working model summarizes the sequence of events through which diminished 
AIF expression in Harlequin (Hq/Y) mice results in elevated oxidative stress and apoptosis in 
mature olfactory sensory neurons. +/Y, littermate control; AIF, apoptosis inducing factor; 
PARP1 and PARP2, poly(ADP-ribose) polymerase 1 and 2; HSP70, heat shock protein 70kD. 
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Figure 5.3.  The schematic summarizes the molecular pathways identified in the Harlequin 
mouse olfactory system in this study and their likely roles in survival vs. cell death decisions for 
mature olfactory sensory neurons (mOSNs). Italicized symbols, proteins down-regulated at the 
mRNA level; non-italicized symbols, proteins up-regulated at the mRNA level; MФ, 
macrophage; AIF, apoptosis inducing factor; LOXL2, lysyl oxidase like-2; CCT4, chaperonin 
containing t-domain 4; PARP1/2, poly(ADP-ribose) polymerase 1/2; CXCL12, CXC-containing 
chemokine 12; AMPH, amphiphysin; DNM1, dynamin 1; FTH, ferritin heavy chain 1; HSP70, 
heat shock protein 70. 
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 The Harlequin mice exhibit clear tissue- and cell-type specific phenotypic differences in 
oxidative damage and apoptosis, possibly due to a difference in sensitivity to the Hq mutation.  
This was also evident in the study reported by Klein et al, in which retinal and cerebellar 
degeneration occurred at temporally distinct stages in various cell types (Klein et al. 2002).  
Furthermore, while progressive oxidative damage and cell death were clearly observed by Klein 
et al and confirmed by our group in the retina and cerebellum of the adult Harlequin mice, 
evidence of degenerative changes was less obvious in most other regions of the brain (Klein et 
al. 2002). Other studies have reported that all brain regions of the Harlequin mice, both the 
degenerative and the apparently protected regions, demonstrated oxidative DNA damage 
(Stringer et al. 2004), suggesting that differences in antioxidant defense, DNA damage repair and 
protein clearance systems may play a major role in the cell- and region- specific phenotypes 
observed. 
 The degenerative changes observed in the olfactory system of Harlequin mice had certain 
similarities to, but several major differences from those in normally aging mice.  The occurrence 
of oxidative stress-associated macromolecular damage was the overall commonality between the 
two. This was highlighted by the occurrence of increased lipofuscin deposits in mitral/tufted cells 
in the OB and in the foot processes of sustentacular cells in the OE of Harlequin mice as early as 
6 months, which were similar in intensity to those observed in the 20-month old aging mice. Yet, 
differences were also evident, including the lack of increase in ferritin heavy chain in the 
mitral/tufted cells in the Harlequin mice, possibly indicating a compromised antioxidant 
response.  This would help explain the occurrence of elevated DNA damage in the mitral/tufted 
cells of Harlequin mice.  Also, in addition to their occurrence in the sustentacular cell foot 
processes, intense lipofuscin deposits were scattered throughout the OE layers in the Harlequin 
mice, indicating more widespread oxidative damage than in normally aging mice.  Other 
differences noted included increased number of apoptotic cells in the OE and marked 
cytoarchitectural changes in the OE and the OB of the Harlequin mice, both of which were far 
more dramatic in the Harlequin mice than in the normally aging mouse olfactory system. 
 Collectively, the results of this dissertation suggest that age-associated oxidative stress 
causes damage to key macromolecules, and, in combination with other factors (such as the Hq 
mutation), can to lead to neurodegeneration.  These conclusions can be extrapolated to the “real 
world”, where aging would be accompanied by cumulative oxidative macromolecular damage 
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due to mitochondrial metabolic decline; oxidative damage would be accelerated by exogenous 
oxidants such as chemical pollutants contributed by the environment; and finally, the genetic 
component would serve as the “third hit” in determining the fate of an individual by either 
protecting or predisposing it to further degeneration and possibly neurodegenerative disorders. 
While the first two components would accompany normal aging and individual lifestyle, the 
third (genetic) component would determine the individual’s inherited vulnerability (e.g. as in the 
Harlequin mouse).  
 Apart from the clearly significant contribution this study has made to the basic 
understanding of olfactory degeneration, the results also provide direction for future mechanistic 
studies and clinical applications.  The lack of timely, accurate and simple diagnostic tests to 
detect the onset and monitor progress of age-associated neurodegenerative diseases such as 
Alzheimer’s and Parkinson’s disease warrants the development of minimally-invasive, sensitive 
and specific biomarker assays.  The identification of differentially regulated genes and proteins, 
which are specific to a disease, in biopsies of the OE or OB, would provide a platform for such 
diagnostic tests.  Further, since specific proteins undergo post-translational modification by 
protein carbonylation, and can be identified reliably using the proteomics methodology described 
here, such protein-specific modifications could serve as a second tier of markers for 
differentiating disease conditions.  Finally, since olfactory sensory decline coincides with early 
(pre-cognitive decline) Alzheimer’s disease, for which reliable early diagnostic tests remain 
elusive, the careful design of such a biomarker assay could provide a method for predicting the 
likelihood of future onset of this disease in an individual, allowing for timely medical 
intervention.  
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CHAPTER SIX 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 The results described in my dissertation provide evidence for oxidative stress-mediated 
molecular and cellular changes in murine olfactory aging and neurodegeneration.  Several 
molecular targets of oxidation were identified in the aging olfactory system. The functional 
consequences of oxidation for each individual protein and its impact on the aging olfactory 
epithelium and bulb remain to be investigated and provide interesting testable hypotheses.  For 
example, the lipofuscin-associated mitochondrial respiratory chain protein ATP5A1 both 
accumulated in the aging olfactory bulb and was specifically carbonylated.  One could 
hypothesize, based on the results described here and what has been reported in literature, that 
mitochondria are specific targets of oxidation in the olfactory bulb, and possibly contribute to the 
cellular debris consisting of dysfunctional proteins and damaged organelles in aging.   
 In this dissertation, I have demonstrated the progressive accumulation of markers of 
oxidative damage in the normally aging olfactory system. The 6-month old Harlequin mouse also 
showed elevated oxidative damage compared to age and gender-matched littermate controls.    
The validation of the Harlequin mouse in this dissertation as a model for oxidative stress-
mediated olfactory neurodegeneration supports the design of future studies on a larger scale to 
investigate progressive changes occurring in the olfactory system of the Harlequin mutant mice.  
It would be of interest to investigate not only the progressive cellular changes, including 
oxidative damage, but also temporal changes in the genes and pathways identified as being 
altered in the olfactory system of 6-month old Harlequin mutant mice.   
 Finally, this dissertation has identified cellular targets of oxidative stress in the olfactory 
system, including mitral cells, astrocytes and olfactory sensory neurons. Future studies could 
investigate the functional consequences of oxidative stress in the cellular targets identified here.  
 Using this study as a platform, there are many directions that future research could take to 
investigate the molecular and cellular changes in olfactory aging and neurodegeneration.  I have 
given some examples here and hope they will spark the imagination and creativity of future 
investigators, realizing that in science there can be boundless directions leading to many 
discoveries which remain unforeseen.  
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